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Abstract

This research focuses on the smoking rates among the Active Duty Air Force
(ADAF) personnel and the association of smoking and cost of hospitalization because
of diseases related to smoking. The analysis of the data taken from the Air Force Web
HA questionnaire provides information about the relationship between the smoking
rates of the ADAF personnel and specific socio-demographic characteristics. The
analysis of a second dataset associated with the cost of hospitalization, provides a list
with the most prevalent diseases related to smoking with the highest cost. Moreover, a
Regression Analysis tries to explore potential predictors that could anticipate the cost
of the most prevalent diseases related to smoking.
The Contingency Analysis showed that smoking in the U.S. Air Force is more
prevalent among the enlisted, males, and the younger age groups. The Pivot Table
Analysis demonstrated that ischemic heart disease and cerebrovascular disease present
the highest cost. In addition, the enlisted personnel exhibit higher total cost compared
to the officers, but the situation is reversed when referring to the average cost.
Furthermore, while smoking is more prevalent among the younger age groups, the
cost consequences of smoking are more intense in the older age groups. The
Regression Analysis exhibited that the variables, related to socio-demographic
characteristics, that explain better the cost of hospitalization are the age group of 4560, the enlisted personnel, and all the pay ranks of the officers, while the diseases that
affect more the cost of hospitalization are ischemic heart disease, cerebrovascular
disease, malignant neoplasms of the urinary bladder, and other arterial diseases.
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SMOKING IN THE UNITED STATES AIR FORCE: TRENDS, MOST
PREVALENT DISEASES AND THEIR ASSOCIATION WITH COST

I . Introduction
Background
Smoking is undoubtedly one of the most severe and serious social issues, and
scientists and sociologists talk about it as a social phenomenon that affects various
fields of human activity. Smoking is not merely a personal choice at the individual
level, but affects society and thereby has become a public and social phenomenon.
Smokers frequently face serious diseases that often lead to death such as lung cancer,
pancreatic cancer, kidney cancer, emphysema, chronic bronchitis, coronary heart
disease and cerebrovascular disease.
Smoking is a harmful habit not just for the smoker, but also for the other
people surrounding the smoker. The detrimental effects of second-hand smoke include
coughing, headaches, sore throat, eye irritation and dizziness. In addition, the
dangerous effects that smoking can have on pregnant women and newborn babies
cannot be ignored. Women who smoke are approximately 30% more likely to
experience infertility than other women. Also, women who continue smoking while
they are pregnant are twice as likely to have problems with their pregnancies in the
third trimester (Diwan, 2010).
Even though anti-smoking campaigns have increased significantly in recent
years and there are no more advertisements or billboards promoting smoking, the
number of smokers increases every year and, accordingly, the number of deaths
caused by the harmful effects of smoking (Mallin, 2002). “Smoking is the leading
preventable cause of death in the U.S. More than 400,000 people die each year due to
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smoking, with $167 billion spent in annual health-related economic losses” (Smith et
al., 2008). The health consequences of smoking result in a substantial economic toll
on people, employers, and society. Smoking results in cost effects that account for
billions of dollars in annual medical care expenditures. The cost effects attributable to
smoking include: cost of hospitalization, cost of physician visits, partial income loss
due to disability and foregone future income due to premature death.
Problem Statement
Smoking among the active duty members of the U.S. military is one of the
most alarming problems. Tobacco use by military personnel is an increasingly
upsetting issue, because tobacco use can affect the alertness and readiness of troops
during their deployment, and the general image and effectiveness of the military.
Recent reports suggest that smoking has become more popular among those on active
duty and especially those deployed in battlefields (Emanuel, 2010). At least one in
three service members is a tobacco user of some sort, according to the Institute of
Medicine (IOM) study (Emanuel, 2010). This number becomes higher when referring
to those service members that are engaged in combat operations (Emanuel, 2010).
Since smoking is clearly an issue that concerns the military, the government has
implemented many measures in the past and continues to do so, in an effort to reduce
smoking rates and eliminate tobacco use among its members. The Department of
Defense (DoD), under the Health Promotion Policy Directive 1010.10 initiated in
1986, tried to improve and maintain the readiness and the quality of life of DoD
personnel by replacing the Directive 6015.18, "Smoking in DoD Occupied Buildings
and Facilities", and establishing a policy on smoking in DoD buildings and facilities
(Arvey and Malone, 2008). Directive 1010.10 was more than a mere educational
program and included restrictions concerning tobacco use. Directive 1010.10 also
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included education and detailed information on the health effects and risks of
smoking, aiming to prevent personnel from smoking and, in this way, enhancing their
quality of life. Although Directive 1010.10 was extended in 1994 by Directive
1010.15 and implemented restrictions on indoor smoking, the tobacco control policy
in DoD has largely remained unchanged, with smoking rates among active duty
members of the U.S. military remaining high (Arvey and Malone, 2008).
The prevalent social problem of smoking in the U.S. military brings about a lot
of consequences such as the aggravation of the DoD healthcare budget, the
deterioration of military fitness levels and the mitigation of deployment readiness.
Tobacco costs the Defense Department more than $1.6 billion a year in medical care
and lost work days. The Pentagon laid out a plan in 1999 to reduce smoking rates by
5% a year by 2001, and could not achieve that goal (Riechman, 2009). Military
tobacco users have been found to be more likely to have injuries during their training
and have a higher probability of discharge within the first year of their service,
compared to non smoking personnel (Klesges et al., 2001). In addition, tobacco users
miss part of their training or miss duty days far more frequently than their nonsmoking cohorts because of an illness related to smoking or aggravated because of
smoking (Klesges et al., 2001). Those military personnel who smoke tend to be less
productive and do not perform satisfactorily on physical tests relative to their non
smoking colleagues (Conway and Cronan, 1988). A study that measured the factors
affecting the performance of the physical fitness tests among the military population
indicated that smoking was a more potent and firmer predictor of physical fitness than
weight (Haddock et al., 2007).
Tobacco use includes the utilization of cigarettes, cigars, pipe tobacco and oral
tobacco forms such as chew, snuff, dip and snooz. The main addictive substance in
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tobacco is nicotine, which could be considered dangerous, as it is an addictive drug in
any form. And like other addictive substances, it creates dependence and subsequently
unpleasant withdrawal symptoms. Researchers have proven that the pharmacologic
and behavioral characteristics that designate nicotine addiction are similar to the
addiction that drugs such as heroin and cocaine provoke (American Heart
Association, 2010). An addiction consists of the good feelings that result when an
addictive substance is present and the bad feelings when it is not present, and nicotine
addiction creates exactly the same symptoms, being one of the hardest addictions to
break. Tobacco use and in the same sense nicotine use, create serious diseases and
increases the risk of developing hardened arteries and heart attacks (American Heart
Association, 2010).
Despite the vast research on the phenomenon of smoking and the heightened
awareness of its detrimental effects upon health, society and government, and the
noticeable publicity about litigation against tobacco companies, statistics indicate that
the percent of adults who smoke in the United States increases every year, with a
more pointed increase in smoking among persons 18 to 24 years of age (Mallin,
2002). After a 40-year decline, the U.S. smoking rate has fluctuated around 20% since
2005. Nearly 47 million adults make use of tobacco and the majority of them are
male smokers and people living under the poverty level. (American Council for Drug
Education, 2010).
Another severe problem associated with smoking and use of tobacco is the
passive or environmental tobacco smoke (ETS), more commonly known as
secondhand smoke. Demographics have shown that between 70% and 90% of nonsmokers in the United States population are subject to secondhand smoke (University
of Minnesota, 2010). It has been estimated that from the smoke emitted from one
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cigarette, only 15% is inhaled by the smoker and the remaining 85% is released into
the air for everyone to inhale. According to one study, secondhand smoke is the third
leading preventable cause of death and disability in the United States after active
smoking and alcohol use (University of Minnesota, 2010).
Tobacco use is one of the most significant health issues that the U.S. military
faces today. In 2002, it was estimated that among military members, 33.8% were
smokers, with the Marines holding the highest rate (38.7%) and the Air Force the
lowest (27.0%) (Pyle et al., 2007). Smoking is responsible for a wide range of health
problems, such as injuries, poor performance on fitness tests, and increased days of
sickness (Pyle et al., 2007). In addition, tobacco use, apart from the harmful health
effects that causes, is a serious financial burden for the U.S. The cost effects of
smoking in the U.S. military result in high healthcare expenses, productivity loss, lost
work days because of absenteeism and early discharge of active duty personnel-something that is more often observed in the Air Force. Air Force recruits who
smoked, compared to non-smokers, were more likely to be discharged prematurely,
burdening the DoD budget with an annual cost of $130 million, exceeding training
expenditures (Klesges et al., 2001).
Additionally, there is concern due to the increased use of smokeless tobacco
among military recruits and military members (Severson et al., 2009). The personnel
of the U.S. military represent a remarkable percentage of the total population using
smokeless tobacco. The use of smokeless tobacco is increasing among military
personnel and its prevalence is found to be approximately twice, compared to the
general population (Severson et al., 2009). Smokeless tobacco is mistakenly believed
to be a safer alternative to smoking tobacco and that its use does not influence human
health as much as smoking tobacco. However, smokeless tobacco has been found to
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be more addictive than smoking tobacco and its users are more likely to become
smokers than non smokeless tobacco users (Ebbert et al., 2006).
Few studies have investigated the reasons that cause smoking initiation among
those who have never smoked, recividism among former smokers, or increased
smoking frequency among current smokers. Some studies provide evidence that
deployment of military personnel in battlefields is an important factor that affects both
smoking initiation and relapse among non-smokers and former smokers, and
additionally increases the tobacco consumption among current smokers (Poston et al.,
2008). The deployment of active military personnel to active combat zones has
increased over the last 20 years, since the U.S. participation in the Gulf War. It has
been noted that there might be a relationship between the deployment and increased
tobacco consumption among current smokers, initiation of smoking among never
smokers or relapse among former smokers (Poston et al., 2008). The reasons most
commonly quoted for smoking initiation or increased tobacco use during deployment
are boredom, operational stress and anxiety. In addition, the lack or the limited
availability of alternative activities such as gyms and movie theaters in an operational
environment could increase tobacco consumption. Moreover, the misconception that
the dangers that smoking causes are minimal, in comparison to the risks the deployed
personnel face in the battlefield and the military environment of an operational theater
may encourage tobacco use or increase the overall attitude of lenience toward
smoking (Poston et al., 2008).
Military smoking is an increasingly important issue, because tobacco use
negatively affects troop readiness and productivity, and in addition increases medical
and training costs (Arvey and Malone, 2008). Given these effects, banning smoking
within the military would be considered by many to be both militarily and fiscally
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prudent. In 1985, the DoD conducted research on military smoking issues and found
that tobacco use rates among military members were significantly higher than U.S.
civilian rates and, additionally, it concluded that smoking affects readiness and
estimated the cost effects of smoking related to healthcare (Arvey and Malone, 2008).
On March 10, 1986, DoD announced an intense anti-smoking campaign through
directive 1010.10 (Arvey and Malone, 2008). Directive 1010.10 was not just a mere
educational program on quitting smoking, but went further than that, setting
restrictions and specifying where individuals could smoke on military installations
and when smoking would be permitted (Arvey and Malone, 2008). Directive 1010.10
also tried to educate and inform military members about the risks of tobacco use and
tried to prevent personnel from initiating smoking, and to help personnel quit.
Practitioners were educated, during the routine health examinations, to advise people
about the risks related to smoking, the health benefits of abstinence and where they
could get help to quit smoking (Arvey et al., 2008). Smoking prohibitions in indoor
facilities were made more specific by Directive 1010.15, an extension of Directive
1010.10. Despite this extension, tobacco control policy has made small steps and has
changed little since 1986 (Arvey et al., 2008).
In conjunction with the policy change, cessation assistance is offered to active
duty military members. The program incorporates education techniques and nicotine
replacement therapy, such as nicotine patches and nicotine gum, to assist in quitting
the harmful smoking habit. The anti-tobacco policy tries to discourage individuals
turning to alternative methods of tobacco use such a chewing or smokeless tobacco.
This policy is amplified by the prescription and use of specific drugs that help kicking
the habit of smoking, such as Chantix and Zyban (Commander, Submarine Forces
Public Affairs, 2010).
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Tobacco smoking deserves special consideration, since it affects the health,
the quality and the readiness of the military personnel. In this way, tobacco smoking
merits increased deliberation as an accessional benchmark of the quality of the
military personnel, for various reasons. One of them is that the DoD suffers a serious
financial burden from tobacco use. In 1998, DoD healthcare costs were estimated to
have been inflated by $584 million annually, and in the same year, it was estimated
that smoking created an additional cost of $346 million because of the annual cost of
lost productivity (Larson et al., 2007). Moreover, smoking negatively affects the basic
military training of recruits. Studies in the Navy found that smoking was one of the
factors that predicted attrition in the first year of service and that 1,500 more recruits
would graduate the after the 15-month period of training, if only non-smokers were
recruited (Larson et al., 2007). The same findings are consistent with studies and
researches on tobacco use in the Air Force. Smoking was one of the strongest
predictors for discharge from training, compared to other predictors like
demographics, education or even alcohol or drug use. In addition, estimates proved
that recruits who smoke are related to an additional encumbrance of $18 million for
the Air Force budget per year, because of excess training costs (Larson et al., 2007). It
should be noted that smokers tend to have higher rates of absenteeism and are more
often subject to injuries, compared to non-smokers. This fact has implications for
organizational costs and productivity and consists of an additional predictor for the
educational credentials and mental ability of the military personnel (Larson et al.,
2007). In conclusion, smoking status could be considered as a predicative personnel
quality benchmark.
Despite the fact that tobacco cessation measures and policies are a significant
component of military health promotion programs, approximately one third of the
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DoD personnel use tobacco, which is a percentage very close to the smoking rate
among U.S. civilians and creates doubts about the physical and mental quality of the
Army Forces (Larson et al., 2007). In addition, the U.S. military has always acted as
a role model for society. Recent studies show that military members see themselves as
role models for the rest of the society and in this way, a smoke-free and healthy
military could be the benchmark of pride and consistency (Hoffman et al., 2008).
Career military members and the military personnel stationed in supervisory roles
should provide appropriate and healthy models. Moreover, they should render
themselves responsible for the transmission and dissemination of an influential
message in changing the conception and admittance of tobacco use by military
members (Nelson and Pederson, 2008).
It is apparent that the issue of smoking has been the subject of ample research,
therefore, considerable literature on the issue exists both in terms of the general
population overall as well as the more specific issues of the United States and the U.S.
military. Studies have shown that recently, the rates of smoking among the general
population of the United Studies have decreased, while other studies have
documented a high predominance of smoking among the military personnel, before
and after their admission into the military (Nelson and Pederson, 2008). Smoking is
more intense among deployed military members, because of stress, boredom, family
separation and lack of other alternatives of entertainment. The military has adopted a
subset of tobacco related objectives, which include the reduction of smoking and the
elimination of the use of smokeless tobacco. The tobacco cessation programs are
focusing on reducing the acute and alarming issue of smoking among the military
members.
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This study focuses on examining and analyzing the smoking rates among the
active duty members of the Air Force of the United States. Smoking is a severe
phenomenon for the Air Force today because it is negatively associated with
readiness, fitness level and health quality of the personnel. Tobacco use in the Air
Force is connected to premature death from diseases related to smoking, economic
losses to society and a remarkable burden on the healthcare governmental budget.
Huge healthcare expenditures and yearly lost productivity are the results of the high
rates of smoking among the Active Duty of Air Force (ADAF). Moreover, this study
tries to classify the most prevalent diseases related to smoking, according to their total
cost, for which ADAF members have been conveyed to hospital. Smoking and high
medical care costs are intimately connected, creating a huge burden on the healthcare
budget of the DoD. In addition, this study makes an effort to detect any potential
relationship between the cost of hospitalization of ADAF personnel because of
smoking related diseases and various predictors related to socio-demographic
characteristics of the population of ADAF.
The rates of smoking among the ADAF can be classified according to age,
gender and rank. Tobacco use is more popular and widespread among the younger
ADAF and especially among the enlisted ranks. Factors such as gender, age group and
pay rank, affect the intensity of smoking, the health standard of the U.S. Air Force
personnel and the magnitude of the relevant economic losses.
The first part of this study is based upon data extracted from the Air Force
Web Health Assessment (AF Web HA) questionnaire, more specifically from the
section of AF Web HA which refers to demographics and questions associated to
smoking and tobacco use. Web HA is an online questionnaire completed by military
members as part of annual medical assessments. The demographics give substantial
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information about the profile of the interviewee which include gender, age and pay
rank. The Tobacco-Use section of AF Web HA gives information about current
smoking status of Air Force personnel and this section is used in this research for
measuring the smoking trends among the ADAF members and their association with
specific socio-demographic characteristics. The Tobacco-Use section of AF Web Ha
questionnaire is given in Appendix A (AF Web HA, 2010).
The second and third part of this study is based on data obtained from the Air
Force Medical Support Agency’s Healthcare Informatics Division (AFMSA/SG6H).
This dataset includes cost data of direct and network care, provided to ADAF
personnel, because of smoking related diseases. The information extracted from this
dataset is used for two purposes:
•

For rating the most prevalent diseases related to smoking, according to
their total cost, and providing additional information associated with the
socio-demographic characteristics of the population

•

For trying to detect any potential relationship between the cost of
hospitalization and various variables affecting this cost

The purpose of this study is to analyze statistically the data obtained from the
AF Web HA records, present the current smoking status of Air Force, and make a
resource about who smokes more according to gender, age and pay rank.
Additionally, this study focuses on the most prevalent diseases that are associated
with smoking, and analyses them on a cost basis, in order to sort them out according
to their cost and track any relationship between this cost and any characteristics
referred to the ADAF members.
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Research Objectives
Research Questions
1) How is smoking affected by the socio-demographic characteristics of the
ADAF population?
•

How is smoking affected by pay rank?

•

How is smoking affected by gender?

•

How is smoking affected by age?

2) Which diseases cost most to the U.S. Air Force, according to their total
cost of hospitalization?
3) How is the cost of hospitalization affected by gender, age, pay rank and
each disease separately?
Research Focus
The initial area of research focuses on determining and measuring smoking
rates in the U.S. Air Force, specifically the active duty members. The measurement of
these rates is based on data, extracted from the AF Web HA questionnaire data, which
gives important information about the tobacco use in Air Force, sorted by gender, age
and pay rank. The secondary area of the research is exploring the hierarchy of the
most prevalent diseases related to smoking, according to their cost and providing
some information about the cost of these diseases, relating it to more specific
characteristics associated with the population of ADAF. The third area of the research
is based on the detection of any predictability of the cost by variables related to sociodemographic characteristics of the ADAF personnel.
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Assumptions
The data sets used in this research demand the establishment of some
assumptions, which allow better manipulation of them to make them useable for this
analysis. Starting with the first data set of AF Web HA, rows with blank cells
referring to age, gender and pay rank were assumed to be erroneous and were deleted.
Moreover, there were some rows referring to the rank of Warrant Officer. Since this
pay rank no longer exists in the Air Force, and the rows referring to this pay rank
were very few, they were deleted. These actions were taken for a better manipulation
of the data set and for the elicitation of undistorted results.
The second data set, including the cost of hospitalization of ADAF because of
diseases related to smoking, was reformulated, as below:
•

The columns Diagnosis 2 up to Diagnosis 9 (Secondary Diagnoses) were
excluded from the data set. Only the Diagnosis 1 column, which includes the
ICD-9 coding of the Primary Diagnosis, was kept for this research.

•

The Primary Diagnosis, and subsequently the whole data set, was restricted
to the ICD-9 codes which refer to the most prevalent smoking related diseases,
according to Smoking Attributable Mortality, Morbidity and Economic Costs
(SAMMEC, 2010). The most prevalent diseases related to smoking and their
ICD-9 codes, according to SAMMEC, are given below in Table 1.
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Table 1. Most Prevalent Diseases Related to Smoking (SAMMEC, 2010)
Disease Category

ICD 9 Codes

MALIGNANT NEOPLASMS
140-149

Lip, Oral Cavity, Pharyx
Esophagus
Stomach
Pancreas
Laryx
Trachea, Lung, Bronchus
Cervix Uteri
Kidney and Renal Pelvis
Urinary Bladder
Acute Myeloid
CARDIOVASCULAR DISEASES
Ischemic Heart Disease
Other Heart Disease

150
151
157
161
162
180
189
188
205
410-414, 429.2
390-398, 415-417, 420-429.1, 429.3429.9

Cerebrovascular Disease
Atherosclerosis
Aortic Aneurysm
Other Arterial Disease
RESPIRATORY DISEASES
Pneumonia, Influenza
Bronchitis, Emphysema
Chronic Airway Obstruction

•

430-438
440
441
442-448
480-487
490-492
496

There were two rows with the index unisex (U) for gender. Those were
deleted.

•

There were three rows with the index Air Force (AF), ten rows with
the indices Warrant 1, Warrant 2, Warrant 3 (W1, W2, W3) and 2 rows
with the index XX for pay rank. Those were deleted.

•

There were 2 rows with the index zero and nine for age. Those were
deleted, also.

•

The cost was expressed in ThenYear Dollars. The use of cost data,
which incorporates time value of money associated with inflation,
demands its conversion to Constant Year Dollars. The procedure and
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method of this conversion is presented and described in a detailed way
in Chapter III.
The above described assumptions were made for a better management of the
data sets and for the exclusion of some erroneous inputs that would distort the
analyses and the results of this study. Furthermore, the restriction of the field of the
research to the most prevalent diseases related to smoking according to SAMMEC
enables the researcher to focus on those diseases that provoke the majority of the
health problems related to smoking and investigate their influence on cost. It is
acknowledged here that ICD codes are judgment calls of the medical provider and
can, in theory, be incorrect. However, for this research, it is assumed that these are
accurate diagnoses. Also note that it is assumed for this research that smoking is the
primary cause of the diagnoses.

Preview
The discussion will begin with a review of the existing literature on smoking
worldwide, in the United States, the Department of Defense and the Air Force. In
Chapter III, the methodology used in this study will be presented, explaining which
methods and what kind of analyses were used in each case. In Chapter IV, a
Contingency Analysis will be developed to determine the rates of smoking among
ADAF. Subsequently, a Pivot Table Analysis will be developed and will be
graphically presented the cost rating of the most prevalent diseases related to
smoking. The next step will be the development and presentation of a Regression
Analysis for the exploration of potential statistical relationship between cost and
various variables regarding the population examined in this study. Finally, the
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conclusions of the research will be discussed, along with the efficacy of the cessation
policy and what additional measures could be taken in the framework of the
promotion of quitting smoking.
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II. Literature Review

Tobacco Use and its Health and Cost Effects Around the World
Numerous studies have been done all around the world focusing on smoking
and the harmful effects on human health and, consequently, on society. The World
Health Organization (WHO) has been dedicated to the fight against smoking for many
years and has conducted many studies on the detrimental consequences of the tobacco
use. Every year WHO organizes campaigns against smoking in numerous countries,
trying to inform people of the adverse health effects of smoking while launching
programs for the cessation of tobacco use. In 2008, WHO published the “WHO
Report on the Global Tobacco Epidemic, 2008: the MPOWER Package.” This report
refers to the smoking problem as a devastating epidemic that threatens the lives of one
billion men, women and children during the 21st century: “Prompt action is crucial.
The tobacco epidemic already kills 5.4 million people per year from lung cancer, heart
disease and other illnesses. Unchecked, that number will increase to more than 8
million a year by 2030” (WHO, 2008).
Tobacco use is spread throughout the world because of successful direct and
indirect marketing, low prices, lack of awareness of its effects on health and the
economy, and ineffective policies against smoking. While the tobacco epidemic might
be destructive, it is preventable and it can be significantly decreased if prompt action
is taken. The WHO has established the MPOWER, a set of six significant measures
against smoking: 1) raise taxes on tobacco products, 2) ban of marketing, sponsorship
and advertisements of tobacco products, 3) the protection of non-smokers and people
that suffer from second-hand smoking, 4) better information and awareness about the
harmful effects and dangers of smoking, 5) offer of help to those who want to try and
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quit smoking and 6) effective monitoring of the tobacco use epidemic and of the
application of cessation policies.
The WHO report emphasizes that there still are crucial issues to be resolved,
in order that further steps can be taken towards the extinction of the smoking problem.
Among these issues are: 1) the weak monitoring and the lack of data on tobacco
related diseases and deaths, which would propel effective tobacco control, 2) the
inadequate implementation of smoke-free laws (only 5% of the global population is
protected by these laws according to the WHO report), 3) insufficient establishment of
cessation programs, 4) the unawareness of the full extent of health risks smoking
induces in the majority of smokers, 5) the economic power of tobacco industries and
the ineffective enforcement of bans on tobacco advertising, promotion and
sponsorship and 6) the relevant low prices of tobacco products and their low taxation.
WHO and the MPOWER set of policies focus on these issues, in order to fight
against the tobacco epidemic. Moreover, this report emphasizes the power of the
tobacco industries and their dynamic marketing of their products. According to the
WHO, the tobacco industry as a whole is a disease vector and spreads its epidemic
through direct and indirect promotion in every angle of the planet.
The developed countries are already experiencing the harmful health and
economic effects of smoking and now on the list are low-income and poor countries
without any tobacco control or effective policies against tobacco use. Poverty is one
of the long-term net economic effects of smoking. The tobacco industry’s objective is
to attract more users and to convert them into addicted smokers and this addiction
disproportionately hurts the poor. After striking the wealthy and developed countries,
smoking strikes poor countries now, augmenting the gap between wealthy and poor
countries, since a smoker in a poor country in order to purchase tobacco, deprives
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himself and his family from basic necessities such as food, shelter, education, and
healthcare. In addition, the tobacco industry targets women and adolescents, trying to
expand its clientele and create more addicted users. The tobacco industry is wellfunded and more politically powerful and its strength can be restricted only through
severe unbiased political action.
Young people and adolescents are also targeted by sophisticated and
misleading advertising campaigns and tobacco industries spend millions on
advertisements, trying to create more smokers, presenting smoking as a kind of
emancipation, glamour and independence (Mackay and Eriksen, 2002). The foreword
of Dr. Gro Harlem Brundtland concludes stating the aim of the Tobacco Atlas and the
Tobacco Free Initiative, which is the enhancement of the global awareness of tobacco
consumption and its effects in every aspect of human life, and the construction of
new and the strengthening of existing actions against the devastating phenomenon of
smoking.
This literature review will focus on several trends, beginning with male
smoking, where worldwide almost one billion males smoke. This includes 35 percent
in developed countries and 50 percent in developing countries (Mackay and Eriksen,
2002). Moreover, the smoking rates among men have peaked but they are declining at
a slow tempo (Mackay and Eriksen, 2002). Educated men tend to give up smoking
more than uneducated men. This fact implies that smoking is transforming into a habit
of the low-education and the low-financial status men (Mackay and Eriksen, 2002).
The current number of female tobacco users is estimated at 250 million
worldwide. This rate is analyzed in more detail, consisting of 22 percent of female
smokers in developed countries and 9 percent of female smokers in developing
countries (Mackay and Eriksen, 2002). The tobacco industries, in an effort to gain
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more female “clients” and expand their market share, promote special advertising
campaigns using misleading icons of emancipation and allurement. In addition, they
launch special tobacco products for women, the so called “feminized cigarettes”,
trying to create more female smokers (Mackay and Eriksen, 2002).
The Atlas makes a reference to youth smoking, mentioning that the majority of
smokers begin using tobacco before reaching adulthood. The factors that contribute to
the rise of smoking rates among adolescents are the specialized tobacco industry
advertising, the relatively low prices of tobacco products and easy access to them.
Starting the harmful habit of smoking during adolescence, makes teenage smokers
even more addicted to it, and expands the danger of contracting smoking related
diseases, such as heart disease and lung cancer, in their 30s or 40s (Mackay and
Eriksen, 2002).
It is very noticeable that, while the consumption presents an image of
stabilization or even decreasing in some countries, worldwide, the number of people
smoking increases, especially because of the expansion of the world’s population.
Those who smoke prefer mainly cigarettes. Ninety six percent of tobacco
product sales are from cigarettes (Mackay and Eriksen, 2002). The Atlas gives a short
list of the regions of the planet that consume the biggest share of cigarette production
worldwide. Tobacco sales and consumption are greatest in: “Asia, Australia and the
Far East (2,715 billion cigarettes), followed by the Americas (745 billion), Eastern
Europe and Former Soviet Economies (631 billion) and Western Europe (606
billion)” (Mackay and Eriksen, 2002).
The Tobacco Atlas focuses on the cost of smoking to the economy and to the
smoker. Commencing with the cost to the economy, the tobacco companies claim that
smoking and subsequently the production of tobacco products benefits the economy
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and if all the tobacco control measures were to go into action, then tax revenues
would decrease dramatically (Mackay and Eriksen, 2002). Many people that work in
the tobacco industry would be unemployed and the economy would be called to face a
serious hardship. But the tobacco companies avoid mentioning the economic losses
that economy suffers from smoking. Tobacco use creates great losses to governmental
economies, to the employers and to the environment because of the healthcare
expenses due to smoking related diseases, absenteeism, decreased productivity, loss of
foreign exchange because of the import of tobacco products, accidents, and
deforestation because of careless fires caused by smoking or loss of land that could be
used to cultivate food instead of tobacco.
Regarding the cost to the smoker, the main cost is the money spent on tobacco
and cigarettes, which diverts money away from buying food, clothing or shelter.
Moreover, a smoker may experience the loss of income because of illness and the loss
of family income because of the time taken by the family members to look after a
smoker. Smokers often have to deal with higher healthcare or insurance expenses,
facts that dramatically decrease their net income.
Education is the most substantial part of the process of tobacco control. All the
anti-smoking measures or any taxation and legislative intervention would not be
meaningful without the understanding of their effectiveness. The purpose of the antismoking education is to focus not only on the harmful effects of smoking, but also
aims to teach people, especially young people, how they could refuse this harmful
habit. The Tobacco Atlas cites the efforts of quitting smoking and which techniques
can be successfully utilized to quit the use of tobacco. The most popular techniques
are: “Social support, clinics, quitlines, internet sites, skills training, nicotine
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replacement therapy (NRT), and other pharmaceutical treatments” (Mackay and
Eriksen, 2002).
The last part of the Tobacco Atlas makes some prognostics about the future of
the tobacco epidemic. The most prevalent prediction is that the tobacco epidemic is
increasing and expanding, while shifting from developed countries to the developing
ones. Moreover, it is predicted that more women will be smoking in the future
(Mackay and Eriksen, 2002). The remiss legislative interventions and the lack of
structured and scientific information about the harmful effects of smoking, and the
role of the powerful tobacco industries in the developing countries reinforce the
expansion of the epidemic. The Tobacco Atlas describes the future as “bleak” unless
immediate and considerable action is taken now. Studies, research reports and the
several anti-smoking policies have proven that smoking rates can be significantly
decreased if every government and nation takes sustained and decisive measures
against the epidemic. (Mackay and Eriksen, 2002)
Smoking and its Effects in the United States
Tobacco use in the United States, along with exposure to tobacco smoke, are
two of the most preventable causes of premature deaths due to chronic diseases,
negative financial effects to society, and an economic impairment of the country’s
healthcare system. It has been estimated that at least 30% of all cancer related deaths,
almost 80% of the deaths associated with chronic obstructive pulmonary disease and
early cardiovascular disease and deaths related to it, are primarily engendered by the
harmful habit of smoking (Adhikari et al., 2008). In order to assess the extent of the
economic loses and the magnitude of the burden on the healthcare system of the
United States because of smoking, the same team of Adhikari et al., conducted a
study, which was an analysis of SAM (Smoking-Attributable Mortality) and of YPLL
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(Years of Potential Life Lost) because of smoking, based on data of the Centers for
Disease Control’s (CDC) SAMMEC (Attributable Mortality, Morbidity, and
Economic Costs) system. The analysis focuses on the years 2000-2004 and indicates
that during this period the use of cigarettes and the exposure to cigarette smoke was
responsible for at least 443,000 premature deaths, approximately 5.1 million YPLL
and $96.8 billion in productivity losses annually in the United States (Adhikari et al.,
2008).
The same analysis uses the sex and the age of the smokers and people exposed
to tobacco smoke as leading variables, and is focused on nineteen adult and four
infant disease categories. According to this analysis, during the period of 2000-2004,
the estimated annual averages of deaths provoked by smoking were 269,655 deaths
among males and 173,940 deaths among females in the United States (Adhikari et al.,
2008).
It is worth mentioning that, among the nineteen adult diseases, the most
prevalent diseases attributable to smoking were lung cancer, ischemic heart disease
and COPD (Chronic Obstructive Pulmonary Disease). Percentages of deaths among
adults 35 years or older, indicate that 41% of smoking associated deaths were
engendered by cancer, 32.7 % by cardiovascular diseases and 26.3% by respiratory
diseases. Along with the adult deaths, it was estimated that 776 infants died annually
due to smoking during pregnancy, and 49,400 cases of lung cancer and heart disease
annually were related to second-hand smoking (Adhikari et al., 2008).
Citing the economic effects of smoking, the same analysis mentions that for
the same period of 2000-2004, the average productivity loss assignable to smoking
was $96.8 billion, where $64.2 billion was attributed to males and $32.6 billion to
females (Adhikari et al., 2008). Even though the smoking rates have declined

23

significantly compared to 1960s when they had reached their peak, the number of
deaths attributed to diseases related to smoking is almost the same, because
population has increased. This increase of the population contributes to the increase of
the absolute number of deaths, even though the rates of smoking attributable diseases
have relatively decreased (Adhikari et al., 2008).
During the period of 2000-2004, the total economic burden of smoking was
$193 billion per year, including healthcare expenditures (which had been calculated to
be almost $96 billion) and productivity losses (approximate estimation was $97
billion). This burden is 325 times larger than $595 million, which was the total cost
of investments in tobacco control and cessation programs in fiscal year 2007
(Adhikari et al., 2008). Tobacco control and cessation programs could expedite the
decline in smoking rates and subsequently the reduction in expenditures related to
productivity losses and healthcare expenditures related to smoking.
Morbidity and Mortality Weekly Report (MMWR) published an article in
September 2010 regarding the national and state adult smoking prevalence, reporting
that even though the prevalence of smoking has declined the past 30 years in the
United States, it continues to be the leading cause of cardiovascular diseases, multiple
cancers and pulmonary diseases. Combined, these diseases cause the death of
approximately 443,000 people annually and encumber the governmental budget with
$ 193 billion annually, including healthcare expenditures and productivity losses.
Even though the smoking rates have decreased over the past 30 years, the
phenomenon of smoking is still one of the most alarming and widespread in the
country (Dube et al., 2010). The report is based on 2009 data from the National
Health Interview Survey. According to this data set, in 2009, 20.6% (46.6 million) of
the adults of the United States were current smokers. Of these 46.6 million smokers,
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36.4 million (78.1%) were regular smokers smoking on daily basis, and 10.2 million
(21.9%) smoked on some days. In addition, smoking was more prevalent among men
(23.5%) than women (17.9%) (Dube et al., 2010). Referencing racial groups,
smoking was less prevalent among Asians (12.0%) and Hispanics (14.5%), compared
to non-Hispanic Blacks (21.3%) and non-Hispanic Whites (22.1%). Smoking was
most prevalent among multiple races (29.5%) and American Indians/Alaska Natives
(23.2%) (Dube et al., 2010). Counting the smoking prevalence according to regions,
the Midwest stands for the highest prevalence (23.1%) followed by the South
(21.8%), and the West with the lowest prevalence (16.4%) (Dube et al., 2010).
Smoking prevalence varies when it is observed by education level. Smoking rates
were higher in 2009 among adults with a General Educational Development
certificate (GED) (49.1%), and they tended to decline as the education level increased,
reaching their lowest value (5.6%) among those with a graduate level degree. It is
remarkable that smoking prevalence was higher among people living below the
federal poverty level (31.1%), compared to those living at or above this level (19.4%)
(Dube et al., 2010). The MMWR article concludes with the importance of tobacco
control and cessation programs, referring especially to the states with the lowest
smoking prevalence (Utah and California) and how successful and effective their
long-running tobacco control programs have been (Dube et al., 2010). The article
emphasizes the importance of anti-smoking strategies, such as price increases on
tobacco products, concise smoke-free policies, and well organized campaigns and
their implementation combined with access to efficient treatments and services.
Centers for Disease Control and Prevention (CDC) website provides valuable
and important information about the smoking trends in the U.S., which correlate with
the information previously given in the article from MMWR. The page is called Fast
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Facts, last updated in September 2010 and last reviewed in October 2010, and besides
the smoking rates of the U.S. in 2009, provides additional financial information,
concerning the money spent in the advertising and promotions by the tobacco
industry, the amounts available for tobacco control programs and the cost of secondhand smoking. The percentages of adults in the United States that were current
smokers in 2009, are given in Table 1 (CDC, 2010):

Table 2. Percentages of U.S. Adults Current Smokers in 2009 (CDC, 2010)
Percentage
Category
All U.S. Adults
20.6 %
American Indian/Alaska Native Adults

23.2 %

White Adults

22.1%

African American Adults

21.3%

Hispanic Adults

14.5%

Asian American Adults

12.0%

An adult is defined as a person 18 years or older and a current smoker is
considered a person who has reported that he/she has smoked at least 100 cigarettes
during their lifetime and at the time of interview declared that they smoked every day
or some days. Each day, approximately 1,000 persons under the age of 18 years old
begin the harmful habit of smoking while every day 1,800 adults of 18 years old or
older, begin tobacco use on a daily basis (CDC, 2010). CDC states that smoking costs
almost $193 billion annually, an amount that consists of $97 billion lost in
productivity and $96 billion in healthcare. A remarkable piece of information is that
second-hand smoking costs more than $10 billion annually, a cost which is composed
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of healthcare expenditures, morbidity and mortality (CDC, 2010). The same web page
provides additional information about the funds spent for tobacco control and
cessation programs. According to this report, in 2008, $24.4 billion was available to
states, funds concentrated by excise taxes and legal settlements, for tobacco control
programs, but only a small percentage (<3%) was spent for this purpose (CDC, 2010).
Moreover, enormous amounts of money were spent by the tobacco industry, in order
to reach its promotion aims. In 2006, $12.5 billion was spent totally for advertising
campaigns (CDC, 2010).
MMWR, in an older article, makes a distinction between smoking morbidity
and smoking mortality. The article talks about the cigarette smoking attributable
morbidity in the United States in 2000 and there is a reference that labels the
difference between morbidity and mortality. Data related to mortality indicate the
number of individuals that die each year because of a disease attributed to smoking,
while morbidity data is associated with the prevalence of persons that bear a disease
affiliated to smoking (MMWR, 2003). The article focuses on the diseases attributable
to smoking morbidity and mentions that in the United States, in 2000, approximately
8.6 million people had serious diseases related to smoking and chronic bronchitis and
emphysema, which are accountable for a percentage of 59% of all smoking
attributable diseases (MMWR, 2003). More specifically the article mentions:
In 2000, an estimated 8.6 million (95% CI=6.9-10.5 million) persons in the
United States had an estimated12.7 million (95% CI=10.8-15.0 million)
smoking-attributable conditions. For current smokers, chronic bronchitis was
the most prevalent (49%) condition, followed by emphysema (24%). For
former smokers, the three most prevalent conditions were chronic bronchitis
(26%), emphysema (24%), and previous heart attack (24%). Lung cancer
accounted for 1% of all cigarette smoking-attributable illnesses. (MMWR,
2003)
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Tobacco Use in the United States Military and Air Force
There is not vast literature on the topic of tobacco use in the U.S. Air Force.
The majority of the articles and the studies focus on the association between smoking
and the enlisted ranks of the Air Force, the use of smokeless tobacco and smoking
during deployment. A common theme of these studies is the necessity of the
implementation of a more active control and cessation smoking policy.
A study on active duty members of the U.S. Air Force, published in 2000,
provides costs of smoking for active duty personnel of the Air Force for the year
1997. The article mentions that almost 25% of male and 27% of female active duty
personnel aged between 17 and 64 years were smokers in 1997 (MMWR, 2000).
Moreover, the estimated costs of current smoking, according to a study conducted in
1997 for the ADAF members, reached approximately the amount of $107.2 million
per year, which was composed of $20 million for medical care expenses and $87
million for lost workdays (MMWR, 2000). The $20 million of healthcare expenses
represent 6% of the total budget of the Air Force delegated to medical care
expenditures and the $87 million of lost workdays was comprised of $76 million for
lost workdays among males and $11 million among females (MMWR, 2000). The
DoD estimated that in 1995, $584 million was spent annually in the healthcare sector
because of smoking attributable diseases and $346 million of lost productivity
occurred.
A similar study, presenting and analyzing the costs of mortality and morbidity
attributed to smoking within the DoD, was conducted by Helyer et al. and published
in 1998, using data from the year 1995 and the methodology of the Centers for
Disease Control and Prevention. The population was comprised of active duty
members of DoD, their families, retirees, and their dependents aged under 69 years

28

old. The study mentions that in 1995, the prevalence of smoking among the active
duty personnel of the DoD was 31.6%. 54.6% of active duty members were never
smokers, while 13.8% were former smokers (Helyer et al., 1998). The study makes a
distinction between direct and indirect costs. The direct costs include direct healthcare
costs, productivity loses and premature deaths. The total direct healthcare costs
counted for $584 million, the largest amount was attributed to hospitalization costs,
77%, while 18% was ascribed to physicians’ fees (Helyer et al., 1998). Male smokers
were responsible for the largest share of the direct healthcare costs, 74%, and the
majority of them belonged to age group 35 to 64 years (Helyer et al., 1998). The study
rates smoking related diseases according to their share of responsibility in provoking a
premature death. The cardiovascular diseases were responsible for 45% of the
premature deaths attributable to smoking, neoplasms and lung cancer accounted for
35% of deaths and respiratory diseases were found at the third place of this
assortment, with the percentage of 19% (Halyer et al., 1998). The premature deaths
associated with smoking accounted for 16% of the deaths in the population of the
DoD, almost one in six deaths (Halyer et al., 1998). In 1995, active duty members
were hospitalized for 9,239 days because of a smoking related disease, and the cost
connected with those days was almost $1 million. The cost of smoke breaks totaled
$345,199,197 (Halyer et al., 1998). Enlisted personnel accounted for the 32.6 % of the
current smokers, while among the officers ranks, 9.5% of smokers was accounted to
the pay ranks O1-O3 and 7.1% to the pay ranks O4-O10 (Halyer et al., 1998).
One of the major concerns of the DoD in recent years is the unhealthy lifestyle
of the military population and its dependents, and its consequences, financial and
social, on the DoD itself. Tobacco use, overweight and obesity, and high alcohol
consumption (referred as “TOBESAHOL”) are the principal unhealthy behaviors of
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the active members of the U.S. military, which adversely affect the quality of their
health level, because of the numerous diseases caused by TOBESAHOL, and create
costs of billions of dollars because of medical care expenses, lost productivity and
premature decay (The Lewin Group, 2010). The Office of the Assistant of Defense,
using the “Military Health System (MHS) Cost of Disease Estimator (CoDE), and
based on a User-defined scenario that includes the TRICARE Prime beneficiary Air
Force population stationed in CONUS,” conducted a report that estimates the rates
and costs of TOBESAHOL among active duty members of the Air Force and their
dependents, and the Air Force retirees aged under 65 years old and their dependants,
for Fiscal Year 2008. Of the $774 million of DoD medical costs due to TOBESAHOL
in 2008, $174 million were attributed to problems generated by smoking (The Lewin
Group, 2010). The tobacco use in this study was defined as the use of cigarettes and
smokeless tobacco. Referring to the smoking rates among the active duty personnel of
the report, an approximate number of 392,000 TRICARE Prime adult enrollees,
expressed in a percentage of 46% of total TRICARE PRIME adult enrollees, were
current smokers, and men were more likely than women to be moderate to heavy
smokers. Correspondingly, young adults were more susceptible to be current smokers
than older adults (The Lewin Group, 2010).
Some years ago a survey was conducted, based on every trainee entering the
USAF enlisted force from August 1995 to August 1996 in order to provide
information on the factors affecting trainees that urge them to smoke. The sample of
the survey consisted of 32,144 trainees entering the enlisted ranks of the USAF for the
period August 1995 – August 1996 and the data were collected on the basis of four
general domains: demographic data, the background of smoking, coefficients related
to tobacco use, and other risk factors. The results showed that the trainees that were
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married, those that came from families with high income, those with low education
level and Euro-Americans were more susceptible to smoke (Haddock et al, 1998). The
survey demonstrated that one of the most forceful predictors of the smoking status of
the trainees, participating in the survey was their concept of the social attractiveness
of smoking (Haddock et al, 1998).
In their research, Klesges et al. showed that 28.5% of the 29,044 recruits who
entered the Basing Military Training (BMT) of the Air Force from August 1995 to
August 1996 were smokers. Smokers were 1.8% more likely to be discharged from
the BMT during the first year, compared to non-smokers. Among the Air Force
recruits, of the 14% discharged, 19.4% were smokers and 11.8% non-smokers
(Klesges et al., 2001). The associated excess training costs of discharged recruits
reached the amount of $18 million per year for the Air Force and assuming that, the
same ratio of recruits prematurely dismissed because of smoking was applied to other
services of U.S. military, the total military annual excess costs of training would
approximately account for $130 million (Klesges et al., 2001). In addition, the
investigation mentions that smoking status, compared to the rest of the demographic
predictive variables used for this study, was the best single predictor of the premature
discharge of recruits from the BMT of the Air Force (Klesges et al., 2001).
Despite the anti-tobacco measures implemented in recent years, such as the
free-of-charge tobacco treatments, the regulation of the prices of the tobacco products,
and the designation of military buildings as smoke free; the smoking trends among the
active duty military personnel in the United States remain high and present an
increasing trend that is remarkably higher compared to civilians (Haddock et al.,
2009). The study was conducted with the aid of 15 focus groups from four USAF
installations and nine focus groups from two U.S. Army installations, and was
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concentrated on junior enlisted personnel and on those who directly supervise them,
aged from 18 to 24 years old (Haddock et al., 2009). The results demonstrated that the
factors that encourage tobacco use among junior enlisted ranks were smoke breaks,
the easy access to tobacco products in the military installations, the social
attractiveness of smoking, anxiety and boredom, and the apprehension of gaining
weight. On the other hand, the factors that discourage tobacco use were the severe
smoking bans in all military installations and vehicles, the inconvenience of smoking
in designated areas, and the influence of the supervisors (Haddock et al., 2009).
Another study, published in 2009, focuses on the reasons for tobacco use
among soldiers of U.S. Army. Soldiers in the Army use tobacco in order to fight
stress, relax, socialize and make friends. Moreover, the majority of the soldiers in this
study believed that the use of tobacco could help them to face the psychological and
physical anxieties derived from the requirements of training and deployment. Some of
them used tobacco products because of issues related to boredom and sleep
deprivation (Nelson et al., 2009). Some of them used Smokeless Tobacco (SLT) as a
less harmful alternative to smoking, despite being well aware of the adverse
relationship between SLT and oral health (Nelson et al., 2009). In conclusion, the
study suggests that the Army regulations and smoking restrictions should be more
severe regarding the use of SLT. The team of Haddock et al. conducted a study in
2001, using the entire population of the Air Force Basic Military Training recruits for
the period August 1995-August 1996, focusing on the use of smokeless tobacco
among this population. The conclusions of this survey revealed that SLT is a powerful
predictor of smoking initiation and the users of SLT appeared to be more susceptible
to risky behaviors, such as dangerous driving (driving while intoxicated, not using
seat belts) and the usage of alcoholic beverages (Haddock et al., 2001). Those who
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tended to make extensive use of SLT were caucasians, while minorities were less
likely to use SLT. SLT is used more frequently by recruits with high-income
household backgrounds, suggesting that low income may be a barrier to the use of
SLT (Haddock et al., 2001). The main finding of the research was the ascertainment
that SLT is a strong predictor for tobacco use initiation, and that anti-smoking and
cessation regulations and measures should include strategies that ban the use of SLT
among the ranks of the Air Force (Haddock et al., 2001).
Many U.S. military personnel report fighting stress with smoking. Stein et al.
investigated the relationship between high levels of stress and tobacco use among
active duty members of the U.S. military, using the survey of Health-Related
Behaviors of the DoD administered during the period September 2002 – February
2003. The study demonstrated that individuals that smoke or use smokeless tobacco,
reported combating higher levels of stress related to family and work issues,
compared to former or never smokers (Stein et al., 2008). Also, 18.39% of the
participants were experiencing stress related to deployment, 15.52% were facing
problems with a coworker, 15.42% were having problems with a supervisor, while
7.82% were combating stress derived from relationships. Finally, 6.24% reported
stress because of health problems (Stein et al., 2008). In all cases, tobacco users were
more susceptible to other negative behaviors, such as drinking alcohol and careless
driving compared to non smokers (Stein et al., 2008). The studysuggested that tobacco
use as a method for coping with stress is not effective and smoking makes an
individual less likely to use “positive coping strategies.”
Another study, similar to the above mentioned, cites the relationship between
cigarette smoking and military deployment, based on analyses conducted during the
period of March 2007 – April 2007. Smith et al. in their study mention that
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deployment is a decisive factor for smoking initiation and particularly for smoking
recidivism. Among individuals that had never smoked before, 2.3% began smoking
after deployment, while among former smokers, the percentage of those who reported
resumption of smoking after deployment was 39.4%. The total percentage of smoking
increase after deployment was 57% (Smith et al., 2008).
A team of researchers attempted to evaluate the smoking status and the status
of tobacco use cessation (TUC) policies implemented for active duty members of the
DoD, using and analyzing data collected from a new Military Treatment Facility
(MTF) TUC evaluation tool in 2007. The study reported that, in 1997, $20 million
was spent for medical care expenses associated with smoking for active duty AF
personnel, and their cost of lost productivity for the same year due to smoking reached
$87 million (Fraser et al., 2009).
In 2004, the medical cost of smoking to the DoD accounted for $1.3 billion,
while a more recent study mentions that the annual cost to the DoD of tobacco use,
comprised of healthcare expenditures, lost productivity, and decreased readiness,
amounts to $1.6 billion (Fraser et al., 2009). The study focuses more on the smoking
trends among the active duty members of the DoD for 2007 and compares them to the
corresponding civilian members. The resulting investigation showed that the
percentage of current smokers among the active duty personnel of the DoD for 2007
was 19.1%, slightly lower than the percentage of current smokers of the general
population of the country for the year 2006, which was 20.8% (Fraser et al., 2009).
Valuable information can be extracted from this study, concerning the rates of lifetime
smoking, current smokers, everyday smokers and someday smokers for the Air Force
(AF) for the year 2007, which are compared to the corresponding rates of the total
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Military Health System (MHS) and the CDC National Benchmark rates, according to
a survey executed in 2006. These rates are given in Table 3.

Table 3. CY 2007 Prevalence Smoking Rates (Fraser et al., 2009)
Prevalence Smoking
Rates Computed for:

CDC
AF

MHS

National Benchmark

Lifetime Smoking

40.7%

46.7%

50.2%

Current Smokers

16.1%

19.1%

20.8%

Everyday Smokers

64.1%

66.3%

80.1%

Someday Smokers

32.9%

33.7%

19.9%

The percentage of users of smokeless tobacco for the Air Force in 2007 was
4.5%, while the prevalence of smokers and users of smokeless tobacco at the same
time was 0.9% (Fraser et al., 2009). The study emphasizes the fact that despite the
implementation of several tobacco controls and cessation programs, the percentages
of smokers in the DoD still remain high, and suggests a series of recommendations.
The tobacco control policy of the DoD should be updated, including more severe
policies such as the pricing of tobacco products sold in military facilities. Moreover,
there should be an “inter-departmental communication” among the several forces of
the DoD, for an enhanced collection of data, concerning the efficacy of the several
anti-tobacco policies and the medication used in them (Fraser et al., 2009). The
Medical Treatment Facilities (MTFs) should apply a more scrutinized observance of
the Nicotine Replacement Therapy (NRT) and non-NRT medications and of their
results, and perform cost-benefit analyses which would provide beneficial information
about the quit rates and the effectiveness of these therapies (Fraser et al., 2009).
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The most recent study about smoking and its association with mental health
disorders among active duty military members was released in February 2011. This
study used data from the 2005 DoD Survey of Health Related Behaviors (HRB)
Among Active Duty Military Personnel in order to extract information regarding the
smoking trends among the four forces of the U.S. military, and the relationship
between smoking and mental health. The survey was based on a population of 13,603
subjects and the majority of the population was aged between 21 and 34 years old.
Sixty-six percent of the population consisted of White, non-Hispanic individuals, 44%
had some college education, 44.6% of the respondents were not married and 49.2% of
the respondents were married with their spouse at home. Moreover, the biggest part of
the population comprised of enlisted subjects, 82.2%, and 56% of them that had been
deployed in the past three years (Schroeder, 2011). The results, regarding the smoking
trends among the four forces of the U.S. military, showed that the Army had the
highest prevalence of smoking at 31.9%, while the Marine Corps accounted for the
lowest percentage of smoking prevalence with 12.9% (Schroeder, 2011).
Regarding the association between mental health and smoking, the
respondents that had received mental counseling in the past were 67% more likely to
smoke. The study reports that the ranks of officers were less likely to smoke
compared to the enlisted ranks. In addition, the survey makes a reference to the
association of smoking and some behavioral characteristics, such as the usage of
alcohol and the absence of physical exercise. The respondents who reported being
“heavy drinkers” were over four times more likely to be smokers, while those who
didn’t perform a workout at least 3 times a week had an increased likelihood of
smoking (Schroeder, 2011). The study underscores the medical and occupational
morbidity for the active duty members of DoD caused by mental disorders and their
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association to smoking. This morbidity could be controlled and subsequently
decreased by providing increased support in the field of diagnosis and treatment of
mental disorders and by launching a more drastic smoking cessation policy for the
members of the DoD (Schroeder, 2011).
Another report, prepared by the Research Triangle Institute (RTI) reported that
the prevalence of cigarette use in the DoD population in 2005 was 32.2%, while the
Air Force had the lowest percentage of prevalence of cigarette use, 23.3%, compared
to the Army, Navy and Marine Corps (Bray et al., 2006). Male smokers exceed
female smokers with 33.5% versus 24.2% prevalence. Among racial groups, Whites,
non–Hispanics are most likely to smoke (36%). Moreover, individuals with an
education level of high school or less are more susceptible to cigarette smoking.
Marital status affects smoking, too, as unmarried participants of the study represent
the highest percentage of smokers, 38.1%. The lowest pay ranks of E1 to E3 had the
highest prevalence of cigarette use, 45.9%, almost ten times larger than the
corresponding prevalence for the pay ranks of O4 to O10 (Bray et al., 2006). For the
Air Force, 14.5% of the respondents reported they started smoking after joining, while
39% of the current smokers among the active duty members confessed they started
smoking after joining the Air Force (Bray et al., 2006). Thirty-three percent of the Air
Force respondents reported that the availability of tobacco products in Air Force
installations makes it easy for someone to smoke, and among the reasons that explain
cigarette use, 24.7% of the Air Force participants of the study, which was the highest
rate, reported cigarette use in order to relax and calm down (Bray et al., 2006).
A significant issue related to smoking is the productivity loss within the DoD.
Smokers present a higher productivity loss compared to the rest of the population, and
the most frequent types of productivity loss are “leaving work earlier, being late for
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work by 30 minutes or more, and working below normal performance level” (Bray et
al., 2006). Moreover, smokers are more susceptive to working accidents than
nonsmokers.
The most recent data available for current smoking rates is for 2008 and notes
that the current smoking prevalence among military personnel is 31%, a rate which
remains mostly steady since 2002. The main contributing factors that keep this rate
unchanged for the last year are stress, deployment, boredom, the easy access to
tobacco products, and in some cases sleep deprivation. Among the four services of
the U.S. military, the Marine Corps present the highest prevalence of smoking, 37%,
and Air Force the lowest at 23%. Rates referring to the use of smokeless tobacco in
the DoD show the Air Force to hold the lowest rate of 9% and the Marine Corps the
highest rate, 22%. The majority of smokers in the DoD are male, single, White,
enlisted, and between the ages of 18 and 20 years old, and usually of low education
level. The goal of the DoD was to implement an anti-smoking policy that could
decrease the smoking prevalence to below 12% by 2010, but this has not been
managed. The Air Force has applied the most severe tobacco control and cessation
measures of all the branches of the U.S. military, including the ban of smoking during
Basic Military Training, restricting smoking to very specific areas, and the prohibition
of smoking advertisements in Air Force publications (Legacy for Longer Healthier
Lives, 2011).
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III. Data and Methodology
Overview
The purpose of this chapter is to define and delineate the data sets and
methodology used to answer the research questions formulated in Chapter I. This
chapter will start with a discussion related to the data sets used for this research, how
the data were aggregated and used and what kind of conclusions and information was
extracted from each of them. The next step will be to discuss what kind of analysis
was used in each data set in order to answer the research questions. This analysis
follows the partition of the research questions, since this partition is compatible with
the nature of the data sets and their use. Next, each analysis will be further analyzed
and presented in a more meticulous way, since each analysis answers questions of
different nature.
In the first data set we have a Contingency Analysis followed by a graphical
presentation of Excel diagrams, while in the second data set we have a Multiple
Regression analysis. The second case is more complicated since the dependent
variable, which is the cost of hospitalization of active duty members of the United
States Air Force, hospitalized because of diseases related to smoking, is explained by
many independent variables associated with age, gender, pay rank, and the frequency
of the appearance of the most prevalent diseases related to smoking which present the
highest cost. The second data set is used, additionally, to elicit information related to
the cost of the diseases and to compose a list of the ten most “expensive” diseases.
The frequency of the appearance of the diseases, mentioned in this list, is used as one
of the independent variables in the regression models, which are built in order to
explain how the cost is affected by the age, gender, pay rank and the diseases
themselves. Lastly, the regression models will be further discussed, focusing on which
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variables are used and why, how the variables were formed, and which diagnostics
tests were used, in order that the validity of the models is better explained.
Data Sources
Two data sets were used in this research in order to deduce the results needed
to answer the research questions. The first data set is a data set based on the Air Force
Web Health Assessment (AF Web HA) questionnaire, answered by active members of
the Air Force, throughout the years 2005 – 2009. The Web HA questionnaire is a part
of the annual Preventative Health Assessment (PHA) exam and it is mandatory for all
Active Duty Air Force members. It is divided into 17 sections, covering demographics
and all the health issues for the member. This research is focused on sections 1 and 8,
which are Demographics and Tobacco Use. The data set was provided by the
Healthcare Informatics Division, AF/SG6H in San Antonio Texas, in November 2010,
and includes information for the period from 2005 to 2009. This data set is used for
the Contingency Analysis and the formulation of the smoking rates among the AF
active duty members according to age, gender and pay rank.
The second data set is a cost data set, presenting the cost of hospitalization
(expressed in Then Year dollars) of the active duty members of Air Force due to a
disease related to smoking, throughout the period 1999 – 2009. The cost data set was
obtained from the Air Force (AF) Medical Support Agency’s Healthcare Informatics
Division (AFMSA/SG6H), located in San Antonio, Texas. The data came from direct
care (on base, either inpatient or outpatient) and network care (off-base, provided by
non-military medical providers). Any on-base cost data is determined using MEPRS
(Medical Expense and Performance Reporting System) criteria. All off-base cost data
represent what is charged to Tricare. For each individual of this data set, there is an
ICD-9 code in column Diagnosis 1, which refers to the primary diagnosis for the
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patient. There are 8 more columns named Diagnosis 2, Diagnosis 3 up to Diagnosis 9
and include additional information, based on ICD-9 coding, about secondary
diagnoses. This research is based on the Diagnosis 1 (primary diagnosis) for the most
prevalent diseases related to smoking, according to the assumptions presented in
Chapter I.
Furthermore, the data set takes into consideration additional information such
as age, gender, and pay grade of the patient and of course the current year,
information that is composed of the independent variables of the regression models
built with this data set. The range of cost fluctuates between $0.00 and $307,063.12,
which created an initial problem in the distribution of the Y response, which in this
case is the Cost. In Appendix B, the primary distribution of Cost is shown and it is
apparent that many outliers exist that make the data set seem erroneous and indicate a
poorly fitting regression line. Avoidance of these outliers led to the partitioning of the
primary data set into 5 subsets. The result of this partition was the creation of the
following 5 subsets presented in Table 4:

Table 4: Five Subsets and their Range of Cost
Five Subsets
Number of Subset

Description

Cost Range in $

1

Low Cost

$0.00 - $600.00

2

Medium Cost

$600.01 – $1,800.00

3

High Cost

$1,800.01 – $11,000.00

4

Very High Cost

$11,000.01 - $30,000.00

5

Extremely High Cost

$30,000.01 – 307,064.00
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The partition of the initial data set and the creation of 5 subsets lead to the
structure of 5 regression models, one for each subset. The development of 5
regression models corresponding to different ranges of cost, verified evidence that for
different levels of cost there are different variables affecting the Y response (cost).
In addition, the second data set of cost was used in a Pivot Table Analysis, for
the extraction of additional information about the cost of hospitalization due to
smoking and its correlation to several socio-demographic characteristics of the Air
Force population and to the most prevalent diseases related to smoking. The
procedure and the purpose of the Pivot Table Analysis are further analyzed later in
this chapter.
Normalization of the Cost Data Set
The second data set, used for building the regression models, is a data set of
the cost of the hospitalization expressed in Then Year Dollars, which are dollars that
include the effects of inflation and/or reflect the price levels expected to prevail
during that year (SCEA, 2011).
The comparison of cost over the course of many years demands the conversion of
Then Year Dollars to Constant Year Dollars. Constant year Dollars are a method of
comparing dollar amounts of several years, without the effects of inflation. In this way
the dollar amounts are showed at the value they would have in a selected Base Year.
The Constant Year Dollars method includes the division of Current Year Dollar
estimates by appropriate price indices. This procedure is also known as deflating
(SCEA, 2011). The conversion from Then Year to Constant Year Dollars is used to
present the value of something over time, excluding the effects of inflation or
deflation. This enables the researcher to compare cost over time and to normalize the
data set and make it more eligible for regression analysis. The method used for
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converting the Then Year Dollars to Constant Year Dollars was based on the Inflation
Calculator of the Air Force. The Inflation Calculator of the Air Force is a tool, which
allows the user to generate any desired set of inflation tables, for any base year,
starting from the year 1949 and ending at the year 2060. This calculator enables the
user to perform inflation conversions without using inflation tables, or, to generate the
Inflations tables and use them in order to execute the appropriate conversions. In
addition, the inflation tables generated by this calculator include all types of expenses
of the Air Force and both the Raw and Weighted inflation indices.
The method used in this research for converting the Then Year to Constant
Year Dollars was based on first generating the Weighted Inflation Indices, using the
year 2009 as the Base Year. For this specific conversion (Then Year to Constant Year
Dollars) it is appropriate to use the weighted indices. The cost data set of this research
has a range of 11 years, from 1999 to 2009. The last year was used as the Base Year.
The use of 2009 as Base Year converts all the Then Year Dollars to 2009 Constant
Year Dollars. The category of expenses used in this research is Operations and
Maintenance (3400), which incorporates the medical expenses for the members of Air
Force. The Air Force Inflation Calculator was used in this research for generating the
Weighted Inflation Indices for Operation and Maintenance (3400), for the period 1999
– 2009, using the year 2009 as the Base Year. These inflation indices are given in
Table 5.
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Table 5. USAF Weighted Inflation Indices Based on OSD (Office of the
Secretary of Defense) Raw Inflation Rates - Base Year (FY) 2009
Fiscal Year

Operations & Maintenance (3400)

1999

0.831

2000

0.843

2001

0.855

2002

0.863

2003

0.876

2004

0.897

2005

0.929

2006

0.952

2007

0.976

2008

0.995

2009

1.007

After generating the inflation indices with the year 2009 as Base Year, the
second step in the process of converting the Then Year Dollars to Constant Year
Dollars is locating the weighted index that corresponds to the Then Year of the
provided dollar amount. The third step is the division of the provided dollar amount
by this weighted index. For example a dollar amount of $100 in Then Year Dollars of
1999 could be converted into Constant Year Dollars of 2009 by dividing the amount
of $100 by the weighted index of 1999. Using Table 5, the amount $100 must be
divided by 0.831. The division of $100 by 0.831 equals $120.34 ($100/0.831 =
$120.34) and thus the 1999 Then Year Dollars is converted into 2009 Constant Year
Dollars. This method of conversion was used for converting the whole cost data set
from Then Year Dollars to 2009 Constant Year dollars.
Contingency Analysis
The first data set, based on the AF Web HA questionnaire, was used to detect
if there is a relationship between smokers (dependent variable) and pay rank, gender,
or age (independent variables). For this purpose, the Contingency Analysis of nominal
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variables was used, determining if a relationship exists between two nominal
variables. Other statistics such as t-tests, regressions and so on, apply to dependent
variables that are continuous.
The Contingency Analysis structures the data into a two-way table showing
the groupings for each of two different variables. Once the contingency table
has been constructed, it is easy to examine if the two variables are
independent. The statistical test to use in this case is the chi-square test for
independence. (Treloar, 2009)
The null hypothesis is that the two variables are independent. In case that the null
hypothesis is rejected, when the chi-square value is large and the corresponding pvalue is low, then a relationship between the two variables is identified.
JMP®, the statistical tool used in this research, when conducting the
Contingency Analysis of two nominal variables, produces the Mosaic Plot, the
Contingency Table and the Tests Report. The Tests Report gives the negative loglikelihood for categorical data, the Degrees of Freedom and the R-square (U) value.
But the most important part of the Tests Report is the two Chi-square statistical tests
of the hypothesis. “The Likelihood Ratio Chi-square test is computed as twice the
negative log-likelihood for Model in the Tests table. The Pearson Chi-square is
another Chi-square test of the hypothesis that the response rates are the same in each
sample category.” (JMP, 2007) The Mosaic Plot is divided into small rectangles and
each rectangle is proportional to a frequency count of interest, and in this research
each rectangle shows the size of smokers and non smokers for each relative group
(pay rank, gender and age), depending on the X-variable used each time. The
Contingency Table appears as a simple two-way frequency table and for each factor
level of the X-variable there is a row (like two rows for gender, one for males and one
for females) and a column for each response level of the Y response (in this research
there are two columns, one for the smokers and one for the non smokers). The
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Contingency Table provides cell quantities, such as Count, Total%, Row%, Col%,
and Expected which were used (in the Microsoft Excel® tool) in this research for a
more graphic presentation of the smoking rates in Air Force and how these rates are
affected by pay rank, gender, and age.
Pivot Table Analysis
The Pivot Tables option in Microsoft Excel® is one of the most powerful
features of Microsoft Excel® and allows rapid, flexible, and dynamic analysis of a
data set. The Pivot Tables feature is the most appropriate and quickest way of
summarizing lengthy data sets into a compact format. Furthermore, it is a helpful tool
which is used to find relationships within data that are hard to discover because of the
amount and length of data, and to organize the data into an easier format to chart. In
this research Pivot Tables was used with the aim to summarize the cost information of
the second data set, after having deflated, and to reveal potential relationships
between cost and a group of variables such as pay rank, age, gender, and diseases. The
Pivot Table analysis was initially the leading tool for classifying the diseases
according to their cost and answering the second research question of this study. In a
second phase, the efficiency of the Pivot Tables was used in a very fruitful way and
more valuable information was extracted for the compact organization of the initial
data set. Apart from the table of the cost ranking of the diseases and the graphical
depiction, the Pivot Table analysis enriched this research with tables and graphs
exhibiting the total and average annual cost of hospitalization of the ADAF personnel
and to the number of medical visits, sorted out by specific socio-demographic
characteristics such as pay rank, gender and age, for the period from 1999 to 2009.
Additionally, The Pivot Tables furnished this research with information which
harmonizes with the subsequent regression analysis of the third research question.
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Regression Analysis
Data Sets
The third research question of this study was answered using the Regression
Analysis of multiple variables. The data set used for the regression analysis was the
cost data, after having been deflated and converted into Constant Year Dollars with
year 2009 as the base year. In this data set, Cost is the Y response. One basic step,
before defining the x variables and creating dummy variables for the development of
the regression modeling, was to analyze the Y response (cost) and see how it looked
like in a Histogram plot. The Distribution option in JMP® produced a histogram of
cost response and since cost was a continuous variable, the Distribution generated a
histogram with a bar chart and an outlier box plot. The histogram demonstrated the
existence of outliers, which are equal to extreme values, and indicated the division of
the initial data set into subsets of different range of cost. The result of this division
was the partition of the data set into five subsets and the construction of 5 regression
models, one for each subset and its correspondent range of cost. The presentation of
the Distribution of the initial data set and the five subsets is included in Appendix A.
Dependent Variable
The dependent variable, of the regression analysis developed in this research,
is the cost of hospitalization of active duty members of Air Force, for the period 1999
– 2009, because of smoking related diseases. The initial data set did not present any
uniformity because of the great range of cost, and for this reason it was subsequently
partitioned into five subsets, using the range of cost as criteria. In this way, five
regression models were built, each one for a different scale of cost, but the dependent
variable for all the models remains the cost.
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Independent Variables
The initial data set consisted of a small number of columns, which were the
primary independent variables. Gender, age, pay rank, and primary diagnosis were the
main columns of the data set, which were the original independent variables. Gender,
pay rank and primary diagnosis were nominal variables while age was a continuous
variable. The original independent variables were inserted into JMP and used for
generating dummy variables, which recoded the independent variables and
distinguished them into different treatment groups, taking the values 0 or 1 in order to
indicate the absence or presence of some of their categorical effect. The following
sections define each of the independent variables.
o Age. The original independent variable ‘Age” was divided into five dummy
variables, each one corresponding to a different age group. There were five
age dummy variables for the following age groups: Age 17-24, Age 25-34,
Age 35-44, Age 45-60 and Age 61-87.
o Gender_1. The dummy variable Gender_1 was derived from the original
categorical variable Gender, with the value 1 assigned to males and 0 to
females.
o Enlisted. This dummy variable was created from the original categorical
variable Pay_Rank and split all the pay ranks into two more general
subcategories: enlisted and officers. All the enlisted ranks were given value 1
and the ranks of officers received value 0.
o CD, OCS. This dummy variable derived from the original categorical variable
Pay_Rank and ascribed value 1 to the ranks of Cadet (CD) and Officer
Candidate School (OCS) and value 0 to the rest of the ranks.
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o E1, E2, E3, E4. Dummy variable derived from the original categorical variable
Pay_Rank and ascribed value 1 to the ranks of Airman Basic (E1), Airman
(E2), Airman First Class (E3), Corporal (E4), and value 0 to the rest of the
ranks.
o E5, E6. Another dummy variable originated from the original Pay_Rank,
which assigned value 1 to the ranks of Staff Sergeant (E5) and Technical
Sergeant (E6) and value 0 to the rest of the ranks.
o E7, E8, E9. This dummy variable was originated from the original
independent variable Pay_Rank and attributed value 1 to the ranks of Master
Sergeant (E7), Senior Master Sergeant (E8), and Chief Master Sergeant (E9),
and value 0 to the rest of the ranks.
o O1, O2, O3. This dummy variable was created from the variable Pay_Rank
and ascribed value 1 to the ranks of Second Lieutenant (O1), First Lieutenant
(O2), and Captain (O3), and value 0 to the rest of the ranks.
o O4, O5, O6. Another dummy variable derived from Pay_Rank, which
assigned value 1 to the ranks of Major (O4), Lieutenant Colonel (O5), and
Colonel (O6), and value 0 to the rest of the ranks.
o O7, O8, O9, O10. This dummy variable originated from Pay_Rank and
attributed value 1 to the ranks of Brigadier General (O7), Major General (O8),
Lieutenant General (O9) and General (O10), and value 0 to the rest of the
ranks.
o Diseases. This continuous variable was a derivative of the original variable
Primary Diagnosis, and it was used as a stepping stone for the creation of the
dummy variables, associated with the cost and the frequency of the appearance
of the diseases. The creation of this variable demanded the use of the table
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with the classification of the diseases according to their cost. This assortment
was part of the research done in the Pivot Table Analysis. This variable
contains values from 1 to 11, according to the cost rating of diseases presented
and described in the Pivot Table Analysis of Chapter IV.
o Dummy variables for Diseases, counted from 1 to 11. These dummy variables
were created from the above described variable “Diseases”, and they are
associated with the cost and the frequency of appearance of the most prevalent
diseases related to smoking with the highest cost (the eleven diseases that cost
the most to the Air Force for the period 1999-2009, assorted by the Pivot table
Analysis presented in Chapter IV). In each of the dummy variables, value 1 is
attributed to the disease referred to the dummy variable, and value 0 to the rest
of the diseases.

Summary of Data
The section of the regression analysis used the data set of the cost of
hospitalization of active duty members of the United States Air Force due to smoking
related diseases, for the period 1999 – 2009. The diseases used in this analysis were
the ones registered in Primary Diagnosis and only the most prevalent diseases
associated with smoking. The dependent variable was the cost, which was first
converted into Constant Year Dollars, using the weighted inflation indices with base
year 2009, of the Inflation Calculator of Air Force. The initial data set was partitioned
into five data subsets because of the wide range of cost and the non-existence of
uniformity. The independent variables used for building the five regression models,
one for each data subset, were five dummy variables for age, gender, separation of the
enlisted and officers’ ranks; seven dummy variables for seven pay rank groups; and
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eleven dummy variables related to the cost rating and to the frequency of the
appearance of the diseases used in this research.
Building the Models
The regression analysis in this research was elaborated by applying Ordinary
Least Squares (OLS) regression to the data subsets described previously. The OLS
regression is the most common form of linear regression which maximizes the amount
of explained variation in the dependent variable by minimizing the sum of squared
distances between the observed responses in the dataset and the responses predicted
by the linear approximation. The general form of OLS regression is given by the
formula below:
yi= βo + β1x1i + β2x2i + …+ βpxpi + εi
In this formula, yi represents the dependent variable or the response, for a specific
observation i. The independent variables, sometimes called control variables, are
given by x1i, x2i, …, xpi for p i observations, The coefficients of each of the p
parameters are represented by β1, β2, …., βp and the intercept or constant term in this
equation is given by β0. The εi represents the residual, which is the difference between
the actual and the estimated function value.
Search for Predictive Variables
The procedure used for the selection of the most predictive regressors (x
variables) was based on the t-statistics of the regressors and their p-values. When
regressing the model with all the regressors, the t-ratio in the Parameter Estimates,
gives the t-statistic test for a test of the null hypothesis that βi = 0. If the null
hypothesis is true for a regressor xi, then this regressor has no effect on the regressant
Y and can be deleted from the regression model. The column “Prob>|t|” in Parameter
Estimates gives the p-values for a two-tailed test of the null hypothesis that βi = 0.
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Small p-values in this column sign that the corresponding regressor (x variable) does
have an effect on the regressant Y and can be used in the regression model. In this
research, for the OLS regression models, x variables were used whose t-statistic pvalues were less than 0.05.
Model Diagnostics
The assessment of the appropriateness of a linear model, built through the
regression analysis process, is based on some statistical indices given by the results of
the regression and on some diagnostic tests. The indices consist of part of the results
of the building process of the linear model, while the diagnostic tests are done by the
researcher, in order to assess if the model fits the data well. The following sections
define which indices were taken into consideration and what tests have been executed
for the assessment of the goodness-of-fit of the models, built in this research.
R – Squared (R2) and Adjusted R – Squared (Adj. R2)
“By definition, R2 is the fraction of the total squared error that is explained by
the model. Thus values approaching one are desirable. But some data contain
irreducible error, and no amount of modeling can improve on the limiting value of R2”
(Annis, 2008). R2 is the relative measure of the predictability of a model and takes
values between 0 and 1. The higher and closer to 1 the R2 is, the better the model. The
R2 measures how well the linear model approximates the real data. Referring to the
values the R2 can take, an R2 equal to 1 means that the regression line perfectly fits
the data. The R2 increases as more variables are added to the model. Here lies the
drawback of the misleading use of the R2: an increased number of variables included
in the model would erroneously increase the value of R2. For this reason, an
alternative R2 is used for the assessment of a model and this is the Adjusted R2. The
Adjusted R2 is an alternative approach of R2, but it penalizes the statistic when
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additional variables are added to the model. The Adjusted R2 is always less than or
equal to R2 and increases only when a new term inserted in the model improves it.
Influential Data Points – Cook’s Distance
The outcome and accuracy of a least squares regression analysis could be
distorted by the existence of one or more influential points. Influential points are data
points with large effect on the slope of the regression line and on the estimated values
and p-values of the independent variables. Including an influential point in the
building procedure of a least squares regression model, could affect the accuracy of
the model and distort the statistical significance of the regressors (independent
variables). Cook’s Distance is the diagnostic test used for detecting potential
influential points. Any data point which, in the Overlay Plot of Cook’s Distance,
presents a value greater than 0.25, indicates that it might be a potential influential
point and should be evaluated and eventually removed. Any points removed because
of a large Cook’s Distance value are mentioned in Chapter IV, and the correspondent
model has been re-built without these points and the new results are given and
compared to the previous ones.
Tests for Normality and Constant Variance
The diagnostic test used in this research for normality of model residuals is the
Shapiro Wilk test. The Shapiro Wilk test demands the distribution of the studentized
residuals, which is used for the test of normality. The test is based on the null
hypothesis that the residuals are normally distributed, and thus the data are normally
distributed. A p-value greater than 0.05 fails to reject the null hypothesis and in this
case, the residuals are normally distributed and the data set is well modeled. On the
contrary, a p-value less than 0.05 rejects the null hypothesis and in this case, the
studentized residuals are not normally distributed and the data not well modeled.
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The Breusch-Pagan test is used to test for homoscedasticity in a linear
regression model. The key assumption in the Breusch-Pagan test is that the variance
of the errors is constant across the observations. If the errors present constant
variance, then they are called homoscedastic. For the assessment of this assumption
the residuals are plotted and the null hypothesis is that the residuals exhibit constant
variance. A p-value larger than 0.05 fails to reject the null hypothesis and in this case
the errors exhibit constant variance and they are homoscedastic.
Multicollinearity
Multicollinearity occurs when two or more variable are collinear, meaning
that they are linearly related and they measure substantially the same thing. In this
case, the overall p-value of the model might be low but neither of the x variables
makes a significant contribution to the model. The assessment method used for
multicollinearity in this research is the Variation Inflation Factors (VIFs). High values
of VIF scores, and particularly VIF scores larger than 5, mean that the fit of the model
is affected by multicollinearity and variables with high VIF scores should be omitted
and combined with other variables, for a better contribution to the model.
The Final Ordinary Least Squares Regression Models
, Five models were built, each one corresponding to a specific subset of the
initial cost data set and to a particular range of cost. For every model presented in
Chapter IV, the following properties are explained:

• The independent variables chosen every time and used in every model
• Information extracted from the Parameter Estimates, such as the estimated
coefficients of each independent variable, the standard errors, the t-ratios, the p-

54

values, which must be less than 0.05 for each variable used in each model in
order for the variable to be predictive and statistically significant, and the VIF
scores.
• Information extracted from the Summary of Fit Section, such as the R2 and the
Adjusted R2, which provides information about the goodness of fit of the model
and how well the regression line fits the real data points.
• The overall p-value of the model, derived from the Analysis of Variance. A pvalue less than 0.05 rejects the null hypothesis that the means are the same, and
in this case, there is significant difference between the different variables.
• The results of the Shapiro Wilk and the Breusch-Pagan tests.

Summary
This chapter outlines the methodology used for analyzing the data sets used in
this study and presents what tools were used in each data set and for the investigation
of each research question. The first research question was answered through the
analysis of the AF Web HA data base, using the Contingency Analysis and the visual
presentation of the results with the aid of Microsoft Excel®. The investigation of the
other two research questions has been conducted with the use of the data set
referencing the cost of hospitalization of active duty members of U.S. Air Force.
Specifically, the second research question was answered through the usage of Pivot
Tables, which supplied the research with a list of the diseases with the highest cost
and with additional valuable information about the total and average cost for each
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group with specific socio-demographic characteristics. The third research question
was investigated with the assistance of Ordinary Least Squares Regression Analysis.
For this regression analysis the most prevalent diseases related to smoking were used,
registered in the Primary Diagnosis, and the initial cost data set was partitioned in five
subsets, each one corresponding to a particular range of cost.
The subsequent chapter, Chapter IV, presents and summarizes the results of
each type of analysis used in this study, and answers each research question framed in
Chapter I. Chapter V emphasizes and highlights the results obtained through the
investigation of each research question.
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IV. Results and Analysis
Overview
This chapter details the results of each of the methods discussed in Chapter III.
First, the Contingency Analysis is presented with all the tables and figures extracted
from this analysis. Information from the Mosaic Plots and from the Contingency
Tables are used in Microsoft Excel®, in order to be presented in a more visual and
descriptive way. Next, the Pivot Table Analysis presents a list with the most prevalent
diseases related to smoking of the highest cost of hospitalization. Similarly, in this
analysis, additional information related to total and average cost of groups sorted by
age, gender and pay rank, is presented in graphs, executed with the aid of Microsoft
Excel®. Finally, in the Regression Analysis section of this research, the models built
for each range of cost and their correspondent results are presented. The results will
be focused mainly on the predictive variables and the power of predictability of each
model.
Contingency Analysis
The Contingency Analysis report shows a Mosaic Plot, a Contingency Table
and a Tests report. The Mosaic Plot is “a graphical representation of the two-way
frequency table of Contingency Table” (JMP 2007). The Mosaic plot consists of
rectangles. The area of each rectangle is proportional to the proportions of the Y
variable in each level of the X variable (JMP 2007). The Contingency Table is a twoway frequency table, with a row for each factor level and a column for each response
level (JMP, 2007). The Tests Report presents the results for two tests to determine
whether the response level rates are the same across X levels (JMP, 2007). In this
chapter, the results of three Contingency Analyses are presented (associated to the
three socio-demographic variables of pay rank, gender and age) and emphasis is given
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to the two Chi-Square tests, which actually are the drivers for the existence or
relationship between smoking and pay rank, gender and age.
Smokers / Non-Smokers versus Pay Rank
The first Contingency Analysis refers to the relationship between Smoking
and Pay Rank. The Mosaic Plot, the Contingency Table and the Tests Report for this
Contingency Analysis are shown below in Figure 1.
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Mosaic Plot

Contingency Table
PAY RANK by SMOKERS/NON SMOKERS
Count
NON
Total %
SMOKERS SMOKERS
Col %
Row %
170521
154814
325335
ENLISTED
42.46
38.55
81.01
87.30
75.05
52.41
47.59
24798
51466
76264
OFFICERS
6.17
12.82
18.99
12.70
24.95
32.52
67.48
195319
206280
401599
48.64
51.36

Tests Report
N
401599

DF
1

Test
Likelihood Ratio
Pearson

-LogLike
4992.3428
ChiSquare
9984.686
9791.725

RSquare (U)
0.0179
Prob>ChiSq
0.0000*
0.0000*

Fisher's Exact Test Prob
Alternative Hypothesis
Left
1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=1 than 2
Right
0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=2 than 1
2-Tail
0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across PAY RANK

Figure 1: Contingency Analysis of Smokers/Non-Smokers versus Pay Rank
In the Mosaic Plot, Pay Rank=1 refers to Enlisted and Pay Rank=2 refers to
Officers. Moreover, the red color represents the smokers and the blue the non
smokers. It is visually obvious that the enlisted are more numerous than officers. In
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addition, more than 50% of the enlisted are smokers, while the majority of the officers
are non-smokers. See Table 6 and Figure 2.
Table 6: Comparison of Smokers and Non Smokers for each Pay Rank
ENLISTED

OFFICERS

SMOKERS

52.41%

32.52%

NON SMOKERS

47.59%

67.48%

Figure 2: Comparison of Smokers and Non Smokers for each Pay Rank

From the table and graph above it can be deduced that the majority of enlisted
members smoke, while the exact opposite phenomenon is observed among the
officers’ ranks. Only 32.52% of the officers’ population consists of smokers, while the
non smokers represent the high rate of 67.48%.
The Contingency Table of Figure 1 gives a couple of percentages for the
smoking status of the Air Force sample of the data set used in the Contingency
Analysis, and of each group separately. The smoking status of the sample is given in
Table 7 and Figure 3.
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Table 7: Smoking Status of the Air Force Population

AIR FORCE

SMOKERS

NON-SMOKERS

48.64%

51.36%

Figure 3: Smoking Status of the Air Force Population
The table and graph show that 48.64% of the ADAF population of the data set
is smoking and 51.36% is not smoking. This leads to the conclusion that the Air Force
population is divided into two large, almost equal, groups: smokers and non smokers.
The percentage of smokers (48.64%) consists of 42.46% enlisted and 6.17% officers.
The distribution of 48.64% is given by Table 8 and Figure 4.

Table 8: Distribution of the Smokers’ Population

AIR FORCE

ENLISTED WHO SMOKE

OFFICERS WHO SMOKE

TOTAL

42.46%

6.17%

48.64%
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Figure 4: Distribution of the Smokers’ Population
The same picture of the distribution of the smokers’ population is given, but more
detailed, if the smokers are considered a population of their own. The following graph
(see Figure 5) presents this distribution. The graph shows that 87.30% of the smokers’
population consists of enlisted and only 12.70% of officers. The percentages are
indeed alarming and show that smoking is more prevalent among the enlisted.

Figure 5: Distribution of the ADAF members that smoke
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The Tests Report, which is the last part of the Contingency Analysis of
Smokers / Non-Smokers versus Pay Rank, gives the results of Pearson and Likelihood
Ratio tests. Both of these test whether the two variables, in this case smoking and pay
rank, are independent or not. Both Pearson and Likelihood Ratio tests have the same
assumptions, and the null hypothesis here is that the variables are independent,
meaning that there is no relationship between them, and more specifically, smoking is
not affected by pay rank. The Chi-Square test compares the observed cell frequencies
with expected cell frequencies, and assumes a null hypothesis that the variables are
independent (JMP, 2007). The expected values are calculated by multiplying the row
total and column total, and then divide by the grand total. “The Chi-Square test is
always valid if there are no empty cells (no cells with a cell frequency of 0), and if the
expected cell frequency for all cells is five or greater” (JMP, 2007). Figure 6 gives
the Contingency Table of Smokers and Non-Smokers for each pay rank with the
observed and expected frequencies, and the results of the Tests Reports.
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Contingency Table
PAY RANK By SMOKERS/NON SMOKERS
SMOKERS

NON
SMOKERS

170521
158228

154814
167107

325335

ENLISTED

24798
37091.2

51466
39172.8

76264

OFFICERS

195319

206280

401599

Count
Expected

Tests Report
N
401599

DF
1

Test
Likelihood Ratio
Pearson

-LogLike
4992.3428
ChiSquare
9984.686
9791.725

RSquare (U)
0.0179
Prob>ChiSq
0.0000*
0.0000*

Fisher's Exact Test Prob
Alternative Hypothesis
Left
1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=1 than 2
Right
0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for PAY RANK=2 than 1
2-Tail
0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across PAY RANK

Figure 6: Contingency Table and Tests Report of Smokers/Non-Smokers versus
Pay Rank
All the cells of the expected cell frequency of the Contingency Table of Figure
6 are greater than five, fact that indicates that the Chi-Square test is a valid test.
Pearson test uses the observed and expected cell frequencies, while the Likelihood
Ratio test uses a more complex formula (Schlotzhauer, 2007). The column
Prob>ChiSq gives very low p-values for both tests. These very low p-values, which
are less than the significance level of 0.01, give enough evidence to reject the null
hypothesis of independence between smoking and pay rank, and indicate a
relationship between the two variables.
The Fisher’s Exact Test is more suitable for small frequency tables and JMP®
performs this test for 2x2 tables, but it cannot be executed for larger tables. JMP®
presents the results for both one-sided test and two-sided test. The 2-tail p-value is the
more suitable test and tests for independence between the two variables, and is
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interpreted the same way as the Chi Square test. The p-value of 2-tail test is very low,
less than the significance level, and in this case the null hypothesis is again rejected,
meaning that a relationship between the two variables, smoking and pay rank, exists.
Smokers/ Non-Smokers versus Gender
In this Contingency Analysis, the existence of relationship between smoking
and gender is examined. The Mosaic Plot, the Contingency Table, and the Tests
Report of this Contingency Analysis are given below in Figure 7.

65

Mosaic Plot

Contingency Table
GENDER by SMOKERS/NON SMOKERS
Count
Total %
Col %
Row %
Expected

FEMALES

MALES

SMOKERS

NON
SMOKERS

31286
7.79
16.02
36.69
41467.5
164033
40.84
83.98
51.85
153852
195319
48.64

53976
13.44
26.17
63.31
43794.5
152304
37.92
73.83
48.15
162485
206280
51.36

85262
21.23

316337
78.77

401599

Tests Report
N
401599
Test
Likelihood Ratio
Pearson

DF
1

-LogLike
3123.7184
ChiSquare
6247.437
6178.605

RSquare (U)
0.0112
Prob>ChiSq
0.0000*
0.0000*

Fisher's Exact Test
Prob Alternative Hypothesis
Left
0.0000* Prob(SMOKERS/NON SMOKERS=1) is greater for GENDER=F than M
Right
1.0000 Prob(SMOKERS/NON SMOKERS=1) is greater for GENDER=M than F
2-Tail
0.0000* Prob(SMOKERS/NON SMOKERS=1) is different across GENDER

Figure 7: Contingency Analysis of Smokers/Non-Smokers versus Gender

66

In the Mosaic Plot, the red color represents the smokers and the blue color the
non-smokers. From the Mosaic Plot, it is easily seen and understood that the majority
of the ADAF population are males. Furthermore, the Mosaic Plot shows that the
majority of females in the Air Force are not smokers, while 51.85% of the male
population is smokers. The picture of smoking status between genders in the Air
Force is better presented by Table 9 and Figure 8.
Table 9: Comparison of Smokers and Non Smokers for each Gender
FEMALES

MALES

SMOKERS

36.69%

51.85%

NON SMOKERS

63.31%

48.15%

Figure 8: Comparison of Smokers and Non Smokers for each Gender
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The data set used for the Contingency Analysis consists of 401,599 ADAF
members and among them, 78.77% are males and 21.23% are females. These
numbers are taken from the Contingency Table, where more detailed information is
provided for this study and is shown below. Since the greatest part of the Air Force
population is comprised of males, it comes naturally that the percentage of smokers
among the male population will be by far higher than the female population. The
difference of the percentages of smokers between the two genders is remarkably large
and is shown in Table 10 and Figure 9.
Table 10: Distribution of Smokers’ Population by Gender

AIR FORCE

FEMALES WHO SMOKE

MALES WHO SMOKE

7.79%

40.84%

Figure 9: Distribution of Smokers’ Population by Gender
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The distribution of Smokers’ Population references the distribution of this
population out of the whole population of the Air Force of the data set used in the
Contingency Analysis. This distribution shows that out of the total population of this
data set, 7.79% consists of female smokers and 40.84% of male smokers. This is
better shown if the smokers are considered a population of their own. The distribution
of the population of the ADAF members that smoke is given below in Figure 10.

Figure 10: Distribution of the ADAF members that smoke by Gender

The graph in Figure 10 shows that 83.98% of the smoking population of the
Air Force consists of males, and only 16.02% females. The gap between the two
genders presented in this case is even larger, when analyzed according to only that
part of the population of the Air Force which smokes.
The Contingency Table gives also the expected frequencies. In this
Contingency Table, all the expected frequencies are larger than five, and this is an
indication that the Chi-Square test, assuming the null hypothesis that the variables are
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independent, is a valid test. The last part of the Contingency Analysis is the Tests
Report, where the assumption of independence between the two variables is tested,
which, in this case, the two variables are smoking and gender. The null hypothesis is
that the two variables are independent and in this case is rejected, since the p-values
of the Pearson and Likelihood Ratio are very low and are below the significance level
of 0.01. This leads to the conclusion that the two variables are dependent and gender
affects the smoking status of the ADAF population. This conclusion is further
confirmed by the 2-tail p-value shown in Fisher’s Exact Test Results. The 2-tail pvalue is really low and is less than 0.10 of the significance level. The null hypothesis
in this case is again rejected and the two variables are dependent, meaning that gender
does affect the smoking status of ADAF members.
Smokers/ Non-Smokers versus Age
The last part of the Contingency Analysis includes the investigation of the
existence of a relationship between smoking and age. This section of the Contingency
Analysis examines if age is a variable that influences smoking, by testing which age
range of ADAF personnel smokes the most. The Mosaic Plot, Contingency Table and
Tests Report are given below in Figure 11.
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Mosaic Plot

Contingency Table
AGEG by SMOKERS/NON SMOKERS
Count
Total %
Col %
Row %
Expected
Age
17-24

Age
25-29

Age
30-34

Age
35-39

Age
40+

SMOKERS

NON
SMOKERS

55993
13.94
28.67
50.81
53598.6
48510
12.08
24.84
51.46
45844.6
31530
7.85
16.14
50.00
30667
26451
6.59
13.54
46.54
27643.8
32835
8.18
16.81
42.51
37565
195319
48.64

54212
13.50
26.28
49.19
56606.4
45752
11.39
22.18
48.54
48417.4
31525
7.85
15.28
50.00
32388
30388
7.57
14.73
53.46
29195.2
44403
11.06
21.53
57.49
39673
206280
51.36

110205
27.44

94262
23.47

63055
15.70

56839
14.15

77238
19.23

401599

Tests Report
N
401599

DF
4

-LogLike
911.14729

RSquare (U)
0.0033

Test
ChiSquare
Prob>ChiSq
Likelihood Ratio
1822.295
0.0000*
Pearson
1816.918
0.0000*
1= age 17 – 24 , 2= age 25-29, 3= age 30-34, 4= age 35- 39, 5= age 40 +

Figure 11: Contingency Analysis of Smokers/Non-Smokers versus Age

71

The Mosaic Plot shows the distribution of ADAF personnel according to their
age and their smoking status. The red color corresponds to that part of the personnel
that smokes and AGEs 1-5 correspond to different age ranges. Number one represents
the age range from 17 to 24 years old, number 2 the age range from 25 to 29, number
three the age range from 30 to 34, number four the age range from 35 to 39 and
number five the age range from 40 years old and up. From the Mosaic Plot it is seen
that the largest part of ADAF personnel belongs to the age groups of 17 to 24 and 25
to 29, and more than half of the population of these age groups is smoking. A better
presentation of the Mosaic Plot is given in Table 11 and Figure 12, where each age
group is divided into smokers and non-smokers, and the distribution of the population
of each age group is better displayed.
Table 11: Comparison of Smokers and Non Smokers for each Age Group
Age
17-24
50.81%
SMOKERS
NON SMOKERS 49.19%

Age
Age
25-29
30-34
51.46% 50%
48.54% 50%

Age
35-39
46.54%
53.46%

Age
40+
42.51%
57.49%

Figure 12: Comparison of Smokers and Non Smokers for each Age group
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From Table 11 and Figure 12 it is deduced that more than half of the
population of the first three age groups consists of smokers. Specifically, the age
group of 30 to 34 years old is nearly evenly split between smokers and non-smokers.
Younger age groups smoke more than middle age groups. The age groups of 35 to 39
and 40 years and up do not smoke that much, but even in these age groups, the
percentages of smokers are not very low. The graph shows that almost half of the
population of ADAF is smoking and this is alarming.
The Contingency Table provides valuable information which is related to
which of the age groups smokes more and how the smoking population is distributed.
It has been shown above, in the first part of the Contingency Analysis, that 48.64% of
the Air Force population of the data set used in this part of this study is comprised of
smokers. In Table 12 and Figure 13, the apportionment of 48.64% of smokers is
displayed according to the five age groups.

Table 12: Apportionment of Smokers to five age groups

Air
Force

ADAF
aged
17-24 who
smoke
13.94%

ADAF
aged
25-29 who
smoke
12.08%

ADAF
ADAF
aged
aged
30-34 who 35-39 who
smoke
smoke
7.85%
6.59%
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ADAF
aged
40+ who
smoke
8.18%

Total

48.64%

Figure 13: Apportionment of Smokers to five age groups

Figure 13 displays graphically the apportionment of smokers to five age
groups and it is shown that the age group that smokes more than the others is the age
group of 17 to 24 years old. On the other hand, the group that smokes the least is the
one referencing the ages from 35 to 39 years old. In Table 12, where the percentages
of smokers for each age group are presented, one can see that the percentages of
smokers corresponding to the age groups of 17 to 24 and 25 to 29 are close to each
other and together they constitute 26.02% of the smoking population out of the whole
ADAF population of the data set. This is alarming for those who investigate and
research the smoking issue in Air Force. More attention should be given to the young
age ranges, where smoking is most prevalent.
The same picture of the smoking population is given, if smokers of the Air
Force are considered a population of their own. The following Table 13 and Figure 14
show in a more detailed way the distribution of the ADAF personnel that smokes
according to the five age groups.
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Table 13: Distribution of the ADAF members that smoke to five age groups
Age
17-24

Age
25-29

Age
30-34

Age
35-39

Age
40+

SMOKERS
(ADAF WHO SMOKE) 28.67% 24.84% 16.14% 13.54% 16.81%

Figure 14: Distribution of the ADAF members that smoke to five age groups

Table 13 and Figure 14 give a more detailed picture of the distribution of the
part of the ADAF personnel that smokes. The age group that smokes more than the
others is the age group of 17 to 24 years old and the group that smokes the least is the
group of 35 to 39 years old. If the percentages of smokers from the age groups 17 to
24 and 25 to 29 years old are added together, they constitute 53.51% of the smoking
population of the Air Force. This means that more than half of the population of
smokers in the Air Force consists of young people from 17 to 29 years old. The most
productive part of the population of the Air Force is the group that smokes the most
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and this is exceptionally alarming for the future health and quality of the USAF
personnel.
In this Contingency Analysis, all the expected frequencies displayed in the
Contingency Table, are larger than five, fact that points out that the Chi-Square test,
testing the independence between the variables with the null hypothesis that the
variables are independent, is a valid test. In the section of Tests Report, there is no
Fisher’s Exact Test Results, since in this case there is no a 2x2 Contingency Table.
The Tests Report includes only the Pearson and Likelihood Ratio p –values. Both
Pearson and Likelihood Ratio p-values are very low and less than the significance
level of 0.01. There is enough evidence to reject the null hypothesis of independence
between the two variables, where in this part of the Contingency Analysis, the two
variables are smoking and age. Smoking and age are dependent and this means that
age influences the smoking status of the ADAF personnel.
Pivot Table Analysis
The Pivot Table Analysis is based on another data set, which includes the cost
of hospitalization of ADAF personnel due to diseases related to smoking. As
mentioned in Chapter III, this data set was restricted to the most prevalent diseases
related to smoking according to SAMMEC, and in this study only those diseases that
had been registered in the Primary Diagnosis were used. The range of time of this data
set covers the period from 1999 to 2009, and all the dollar values associated with the
total cost of hospitalization because of diseases related to smoking, are expressed in
Constant Year Dollars with base year as the year 2009. The Pivot Table Analysis
begins with the presentation of a hierarchical list of the diseases with the highest cost,
which is used later in the Regression Analysis for the creation of Dummy Variables.
Furthermore, the same data set can be manipulated very easily with the aid of Pivot
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Tables, a tool of Microsoft Excel®, tables and graphs are created, displaying
additional information about the cost of hospitalization through the period 1999-2009
and the total and average cost of hospitalization for groups with specific sociodemographic characteristics related to age, gender, and pay rank.
Most Prevalent Diseases Related to Smoking and their Cost
As mentioned before, the data set used in the Pivot Table and Regression
Analysis was narrowed to the most prevalent diseases related to smoking, according
to a list of 18 diseases provided by SAMMEC. The total cost of hospitalization of
those diseases was added throughout the years 1999-2009, and the result of this
summation was the following list of the most prevalent diseases related to smoking
with the highest cost, given in Table 14.
Table 14: Most Prevalent Diseases Related to Smoking with the Highest Cost

ISCHEMIC HEART DISEASE
CEREBROVASCULAR
DISEASE
MALIGNANT NEOPLASMS
OF TRACHEA, LUNG,
BRONCHUS
MALIGNANT NEOPLASMS
OF LIP, ORAL, CAVITY,
PHARYX
OTHER HEART DISEASE
MALIGNANT NEOPLASMS
OF KIDNEY AND RENAL
PELVIS
MALIGNANT NEOPLASMS
OF URINARY BLADDER
BRONCHITIS, EMPHYSEMA
MALIGNANT NEOPLASMS
OF PANCREAS
OTHER ARTERIAL DISEASE
OTHERS

MOST PREVALENT
DISEASES RELATED TO
SMOKING WITH THE
HIGHEST COST
$22,195,207.61
$14,792,633.79

HIERARCHICAL RANK OF THE
MOST PREVALENT DISEASES
RELATED TO SMOKING
ACCORDING TO THEIR COST
1
2

$2,069,133.88

3

$1,863,827.99

4

$1,548,527.68
$1,445,977.67

5
6

$1,038,325.76

7

$968,831.96
$753,908.61

8
9

$743,624.50
$1,773,335.43

10
11

From Table 14, it is deduced that the most “expensive” disease related to
smoking is ischemic heart disease, with a cumulative cost of $22,195,207.61
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throughout the years 1999-2009. The second place in the list is occupied by the
cerebrovascular disease, with a cumulative cost of $14,792,633 for the period 19992009. It is seen that between these two diseases with the highest cost, there is a gap of
approximately $12,000,000, which is a remarkably big gap. Ischemic heart disease is
by far the disease with the highest cost because it is the most prevalent disease related
to smoking compared to the rest of the diseases related to smoking. The rest of
diseases present a cumulative cost of less than $2,000,000. This cost difference
between ischemic heart disease and the rest of the diseases emphasized the
importance that should be given to the prevention of this disease. Row 11 in the
hierarchical ranking of the diseases includes the rest of the SAMMEC most prevalent
diseases related to smoking and these diseases are presented in Table 15.

Table 15: Other Most Prevalent Diseases Related to Smoking
OTHER MOST PREVALENT RELATED TO
SMOKING DISEASES
ATHEROSCLEROSIS
MALIGNANT NEOPLASMS
OF ESOPHAGUS
MALINGNANT NEOPLASMS
OF CERVIX UTERI
PNEUMONIA, INFLUENZA
CHRONIC AIRWAY OBSTRUCTION
AORTIC ANEURYSM
MALIGNANT NEOPLASMS
OF STOMACH
MALIGNANT NEOPLASMS
OF LARYNX

The classification of the most prevalent diseases related to smoking according
to their cumulative cost for the period 1999-2009, with number one being the disease
with the highest cost, is used in the Regression Analysis of this study for the creation
of dummy variables. These dummy variables are used as regressors, trying to see
which diseases affect the overall cost. The dummy variable of disease one refers to
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ischemic heart disease, the dummy variable of disease two refers to cerebrovascular
disease and so on, and the dummy variable of disease 11 refers to the list of the rest of
the most prevalent diseases related to smoking. A graphical presentation of the
diseases and their classification according to their cost is given by Figure 15.

Figure 15: Most Prevalent Diseases Related to Smoking with the Highest Cost
With the aid of the graph, the cost gap between ischemic heart disease and the
other diseases is visually presented. The total cost of all of the diseases, for the period
that covers the years from 1999 to 2009, reaches the amount of $49,193,334. The
distribution of this amount throughout the 11 year period from 1999 to 2009 is given
by Table 16 and in a graphic by Figure 16.
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Table 16: Total Annual Cost of the Most Prevalent Diseases Related to
Smoking for the period 1999-2009
CY
TOTAL ANNUAL COST
1999
$905,758.27
2000
$2,986,421.97
2001
$3,932,715.58
2002
$3,900,035.24
2003
$2,221,221.96
2004
$5,257,462.32
2005
$5,496,775.31
2006
$5,631,356.73
2007
$6,787,907.41
2008
$7,106,103.24
2009
$4,967,576.85
$49,193,334.87
GRAND TOTAL

Figure 16: Total Annual Cost of the Most Prevalent Diseases related to
smoking for the period 1999-2009
The graph in Figure 16 shows that the year with the highest total annual cost
of hospitalization for ADAF members was 2008, where the total annual cost reached
the amount of $7,106,103. The total annual cost and the grand total cost (the total cost
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for the period 1999-2009) of hospitalization for males is remarkably higher than the
corresponding one for females. Table 17 and Figure 17 give a better picture of the
total annual cost for each gender.

Table 17: Total Annual Cost per Gender
TOTAL ANNUAL COST
FEMALES
MALES
$125,110.65
$780,647.62
1999
$389,391.21 $2,597,030.76
2000
$435,860.60 $3,496,854.98
2001
$534,830.03 $3,365,205.21
2002
$207,179.58 $2,014,042.39
2003
$398,987.13 $4,858,475.18
2004
$579,500.25 $4,917,275.06
2005
$568,850.70 $5,062,506.02
2006
$830,986.43 $5,956,920.97
2007
$1,510,656.23 $5,595,447.01
2008
$598,674.02 $4,368,902.83
2009
Grand Total $6,180,026.84 $43,013,308.03

Figure 17: Total Annual Cost per Gender
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Throughout the years 1999-2009, the cost of hospitalization for the male
population of the Air Force is always higher than the corresponding cost for the
female population. Hospital expenses for males reached their maximum in 007
($5,956,920), while analogous expenses for females reached their maximum in 2008
($1,510,656). In 2008, hospital expenses for female ADAF surpassed the limit of
$1,000,000 for the first time.
The average cost of hospitalization for each gender is almost the same, and in
one year, the average cost regarding females was higher than that one regarding
males. There is no major difference between the grand average cost (the average cost
for the period 1999-2009) for both genders. The following Table 18 and Figure 18
show the average annual cost per gender, while Table 19 and Figure 19 present the
grand average cost per gender.
Table 18: Average Annual Cost per Gender
AVERAGE ANNUAL COST
FEMALES

MALES

1999

$1,097.46

$1,107.30

2000

$1,035.61

$1,057.42

2001

$945.47

$1,202.08

2002

$936.66

$996.21

2003

$3,092.23

$4,178.51

2004

$1,461.49

$2,809.99

2005

$2,138.38

$2,676.80

2006

$1,644.08

$2,387.97

2007

$1,486.56

$2,018.61

2008

$2,452.36

$1,925.48

2009

$1,153.51

$1,575.51
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Figure 18: Average Annual Cost per Gender

Table: 19: Grand Average cost per Gender

GRAND AVERAGE COST

FEMALES

MALES

$1,480.96

$1,774.04

Figure 19: Grand Average cost per Gender
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The above tables and figures present the average annual cost and the grand
average cost per gender. In all cases, it is ascertained that the average annual costs for
both genders are very close to each other. The average annual cost for males is always
slightly higher than females, but in the year 2008, the female average annual cost
surpassed the cost for males. The best way to measure and compare the average cost
for each gender is the grand average cost per gender, which is the average cost for
each gender for the whole period of 1999-2009. The graph in Figure 19 displays the
bar chart of the grand average cost for each gender and is is shown that both genders
do not differ that much concerning the average cost of hospitalization. It is
understood that even though men are a larger portion of the military population, the
average cost is almost the same for both men and women and the expenses of
hospitalization do not differ considerably.
Another way to test if there is a significant difference between the average
annual cost of each gender is the paired t-test. The paired t-test is a statistical test that
compares the means of two groups of observations and tests to see if the average
difference is significantly different from zero. The null hypothesis in this case is that
there is no significant difference between the average annual cost of the two genders,
and the alternative hypothesis is that there is significant difference between the
average annual cost of the two genders. The paired t-test for the average annual cost
of females and males is conducted with the significance level of α=0.05. If the
significance value of the two-tailed paired t-test is less than the significance level of
α=0.05, the null hypothesis is rejected and there is significant difference between the
average annual cost of the two genders. The results of the paired t-test of the average
annual cost of the two genders are shown below in Figure 20.
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FEMALES
Mean
1585.801
Variance
491376.5
Observations
11
Hypothesized Mean Difference
0
df
18
t Stat
-1.12712
P(T<=t) one-tail
0.137246
t Critical one-tail
1.734064
P(T<=t) two-tail
0.274492
t Critical two-tail
2.100922

MALES
1994.170909
952592.7179
11

Figure 20: Two-Tailed Paired T-Test of the Average Annual Cost of
Females and Males

It is seen in Figure 20 that the significance value of the two-tailed paired t-test
of the average annual cost of the two genders equals to 0.274492, which is larger than
the significance level of α=0.05. This indicates that the test fails to reject the null
hypothesis and there is no significant difference between the average annual cost of
females and males.

Age is another point of reference for the ADAF population. It is worth
investigating the cost of hospitalization due to diseases related to smoking, with age
being the point of reference for this cost. Total and average cost for each age group
would be part of this investigation, and Tables 20 and 21 and Figures 21 and 22
provide valuable information for the grand total (the total cost during the period 19992009) and average cost of each age group of the Air Force population of the data set
used for this part of the analysis.
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Table 20: Grand Total Cost per Age Group
GRAND TOTAL COST PER AGE GROUP
$3,330,039.14
17-24
$5,155,190.27
25-32
$14,090,162.82
33-40
$18,280,958.56
41-48
$7,059,219.94
49-56
$1,252,358.03
57-64
$22,817.90
65-72
$1,391.73
73-80
$1,196.47
81-88
GRAND TOTAL
$49,193,334.87

Figure 21: Grand Total Cost per Age Group
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Table 21: Average Cost per Age Group
AVERAGE COST PER AGE GROUP
$1,423.09
17-24
$1,524.30
25-32
$1,602.98
33-40
$1,854.81
41-48
$2,099.71
49-56
$1,920.79
57-64
$950.75
65-72
$173.97
73-80
$239.29
81-88
GRAND AVERAGE
$1,731.00

Figure 22: Average Cost per Age Group

Table 20 and Figure 21, presenting the grand total cost for each age group,
show that the age group 41-48 is the group with the highest cost. The second highest
grand total cost is for the age group 33-40 and the third is the age group 49-56. This
classification of cost by the age groups indicates that ADAF personnel age33- 56
years that smoke, generate the highest cost of hospitalization. The picture of cost
ranking by the age groups is slightly different when average cost is classified by the
age groups. Table 21 and Figure 22 show that the age group with the highest average
cost for the period 1999-2009 is the age group of 49-56 with an average cost of
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$2,099.71, followed by the age group 57-64 with an average cost of $1,920.79, and
age group 41-48 with an average cost of $1,854.81. It is inferred that the age groups
of 41-48 and 49-56 are the groups with the highest grand total and average cost, and
they are the age groups receive the most medical care due to diseases related to
smoking. At this point it must be mentioned that the grand average cost, which is the
general average cost of hospitalization for the whole population of the Air Force of
the data set used in this part of the analysis is $1,731.
The above conclusions about the total and average cost of each age group can
be visualized also by using thefrequency of visits to the hospital or to the doctor by
the above mentioned age groups. Table 22 and Figure 23 show the frequency of visits,
classified by age groups.

Table 22: Frequency of Visits per Age Group
FREQUENCY OF VISITS
PER AGE GROUP
2,340
17-24
3,382
25-32
8,790
33-40
9,856
41-48
3,362
49-56
652
57-64
24
65-72
8
73-80
5
81-88
GRAND TOTAL 28,419
OF VISITS
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Figure 23: Frequency of Visits per Age Group

The age group with the highest number of visits is the age group of 41-48,
with the age group of 33-40 following in second place. The same groups were among
the ones with the highest grand total and average cost. The age groups of 25-32 and
49-56 have almost the same number of visits, and the age group of 49-56 was the one
with the highest average cost. This classification of the frequency of visits, combined
with the classification of grand total and average cost by the age groups, leads to the
conclusion that smoking related diseases are most prevalent in the age range of 33 56.
Table 23 and Figure 24 give a visual presentation of the classification of
diseases related to smoking, according to the frequency of visits (the frequency that
ADAF personnel visited a hospital or a doctor because of a smoking related disease).
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Table 23: Classification of Smoking Related Diseases by the Frequency of Visits
1
2
3
4
5
6
7
8
9
10
11

SMOKING RELATED
DISEASES
ISCHEMIC HEART DISEASE
CEREBROVASCULAR DISEASE
BRONCHITIS, EMPHYSEMA
OTHER ARTERIAL DISEASE
ATHEROSCLEROSIS
MALIGNANT NEOPLASMS
OF LIP,ORAL CAVITY, PHARYNX
OTHER HEART DISEASE
MALIGNANT NEOPLASMS
OF TRACHEA, LUNG, BRONCHUS
MALIGNANT NEOPLASMS
OF KIDNEY AND RENAL PELVIS
MALIGNANT NEOPLASMS
OF URINARY BLADDER
OTHER DISEASES

FREQUENCY
OF VISITS
12482
8133
1977
1005
927
766
666
639
545
527
752

Figure 24: Classification of Smoking Related Diseases by the Frequency of Visits

This classification of diseases differs from the previous one showing the
diseases with highest cost. Ischemic heart disease and cerebrovascular disease are the

90

two diseases with the highest cost and with the largest number of visits. The two
assortments of diseases are not identical and this leads to the conclusion that a disease
of high cost is not necessarily a disease with a large number of visits. That means that
some diseases cost more than others and total cost is independent of the frequency of
visits. In this case, the category Other Diseases includes the following: malignant
neoplasms of cervix uteri, malignant neoplasms of esophagus, malignant neoplasms
of pancreas, pneumonia- influenza, chronic airway obstruction, aortic aneurysm,
malignant neoplasms of stomach and malignant neoplasms of larynx.
The last part of the Pivot Table Analysis includes a concentrated presentation
of the cost of hospitalization of ADAF personnel during the period 1999-2009. Table
24 presents the grand total and average cost for the pay ranks of enlisted and officers
and the grand total cost for the two genders separately.
Table 24: Concentrating Table of Cost for each Pay Rank and Gender
GRAND TOTAL COST
FREQUENCY OF
VISITS
GRAND AVERAGE
COST
MALES
FEMALES
TOTAL

ENLISTED
$33,571,520.94

OFFICERS
$15,621,813.92

GRAND TOTAL
$49,193,334.87

21,103

7,316

28,419

$1,590.84
$29,440,395.99
$4,131,124.95
$33,571,520.94

$2,135.29
$13,572,912.04
$2,048,901.88
$15,621,813.92

$1,731.00
$43,013,308.03
$6,180,026.84
$49,193,334.87

From the above table, it is worthwhile noticing the grand total cost, frequency
of visits, and the grand average cost for enlisted and officers. Here, the word ‘grand’
refers to the whole period of 1999-2009. Enlisted personnel are the majority and it
comes naturally that their grand total cost and their frequency of visits are much
higher than officers. But when it comes to the grand average cost, the grand average
cost of officers is surprisingly higher than for enlisted. This means that the cost of
hospitalization for an officer is higher than for an enlisted and since cost depends on
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the kind of the disease and not on the pay rank, officers might be hospitalized for
more “expensive” diseases, meaning that high-cost diseases are more prevalent among
officers than enlisted. Figures 25 and 26 give a visual presentation of the grand total
and the average cost of enlisted and officers.

Figure 25: Grand Total Cost for each Pay Rank

Figure 26: Grand Average Cost for each Pay Rank
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Regression Analysis
Data Set 1 – Cost Range $0.00 - $600.00 – Model 1
As mentioned in Chapter III, the initial cost data set used for the Regression
Analysis was divided into five subsets with different cost range. The first model, built
in this part of the Regression Analysis, covers the cost range of $0.00 to $600.00. The
Actual by Predicted Plot, the Summary of Fit, the Analysis of Variance (ANOVA)
and the Parameter Estimates Report of this model are given in Figure 27.
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Actual by Predicted Plot

Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error

0.05878
0.058329
160.6838

Mean of Response
Observations (or Sum Wgts)

207.9587
18819

Analysis of Variance
Source
Model
Error
C. Total

DF
9
18809
18818

Sum of Squares
30328082
485634728
515962809

Mean Square
3369787
25819

F Ratio
130.5144
Prob > F
<.0001*

Parameter Estimates Report
Term
Intercept
AGE 45-60
ENLISTED
O1,O2,O3
DUMMY FOR DISEASE 1
DUMMY FOR DISEASE 4
DUMMY FOR DISEASE 7
DUMMY FOR DISEASE 10
O4,O5,O6
CD,OCS

Estimate
299.06179
-12.00913
-102.9175
-107.1333
-12.3346
62.903319
47.597783
37.920519
-94.54707
36.904421

Std Error
3.444336
2.838979
3.440053
6.055061
2.50661
8.005478
9.477384
5.832891
4.402874
18.39044

t-ratio
86.83
-4.23
-29.92
-17.69
-4.92
7.86
5.02
6.50
-21.47
2.01

Prob>|t|
0.0000*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.0448*

VIF
.
1.1378766
1.9634411
1.3153296
1.1141692
1.0239846
1.0169059
1.0430684
1.8204513
1.0304815

Figure 27: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and
Parameter Estimates for Cost range $0.00-$600.00

In this first model, the most predictive variables for cost, with the lowest pvalues of the t-statistic test, appear to be the following ones: AGE 45-60, ENLISTED,
O1-O2-O3, O4-O5-O6, CD-OCS and the dummy variables for diseases 1, 4, 7 and 10.
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All the variables were explained in Chapter III except for the dummy variables of the
diseases. The most predictive diseases in this model are the following ones: disease 1
refers to Ischemic Heart Disease, disease 4 refers to Malignant Neoplasms of Lip,
Oral, Cavity and Pharyx, disease 7 refers to Malignant Neoplasms of Urinary Bladder
and disease 10 corresponds to Other Arterial Disease. The OLS regression model for
the subset of $0.00 - $600.00 is given by the formula below:

Cost = 299.06-12.01*(AGE 45-60)-102.92*(ENLISTED)-107.13*(O1,O2,O3)12.33*(Ischemic Heart Disease)+62.90*(Malignant Neoplasms of Lip, Oral, Cavity,
Pharyx)+47.60*(Malignant Neoplasms of Urinary Bladder)+37.92*(Other Arterial
Disease)-94.55*(O4,O5,O6)+36.90*(CD, OCS)

All the Variation Inflation Factors (VIF scores) of this model, which measure
the redundancy among the explanatory variables, are below 5, meaning that no
multicollinearity occurs. The p-value of F -statistic, which measures the overall
model statistical significance, is shown in the Analysis of Variance in the Prob>F
column. In this model, the p-value of F-statistic, for a 95% confidence level, is lower
than 0.05 and indicates a statistically significant model. Both R2 and Adjusted R2 are
presented in the Summary of Fit, and are values that measure the model performance.
In this model both values are almost the same and equal to 0.058, indicating that this
model explains approximately 5.8% of the variation in the dependent variable, which
in this case is the cost of hospitalization. The particular low R2 value and subsequently
the low predictability of the model, indicate that the model does not provide a good fit
of variables with the data and there is lot of variability not explained by the model.
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The Cook’s Distance Overlay plot in Figure 28 shows that there are no
influential points.

Figure 28: Overlay Plot of Cook’s Distance for Model 1

The diagnostic test for Normality is the Shapiro-Wilk test, which demands a
distribution of the studentized residuals. In the case of Shapiro-Wilk test, a p-value
larger than 0.05 fails to reject the null hypothesis that the residuals are normally
distributed. In this model the Shapiro Wilk test and the distribution of studentized
residuals are given in Figure 29. The p-value is 0.01, lower than 0.05, and that means
that the null hypothesis that the residuals are normally distributed is rejected, and the
model does not pass the test for normality.
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Fitted Normal
Parameter Estimates
Type
Location
Dispersion

Parameter
µ
σ

Estimate
-2.563e-7
1.0000346

Lower 95%
-0.014289
0.9900331

Upper 95%
0.0142884
1.0102416

Goodness-of-Fit Test
KSL Test
D
0.107328

<

Prob>D
0.0100*

Figure 29: Shapiro-Wilk Test for Normality for Model 1

The test for constant variance is the Breusch-Pagan test, and tests if the
variance of the errors is constant across the observations. In the Breusch-Pagan test,
the null hypothesis is that the residuals exhibit constant variance and a p-value larger
than 0.05 fails to reject the null hypothesis. This model fails to pass the BreuschPagan, since the p-value is very low, lower than 0.05 and thus the null hypothesis is
rejected. The results of the Breusch-Pagan test were calculated with the aid of
Microsoft Excel and are given in Table 25.
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Table 25: Breusch-Pagan test for Model 1
Input
SSR 6.222E+10
Test Stat 46.71536
SSE 485634728
P-value 4.43E-07
N
18819
df (reg)
9

Data Set 2 – Cost Range $600.01 - $1,800.00 – Model 2
In Model 1 there was a lot of variability not explained by the data and for this
reason the model demonstrated low predictability, even though the predictive
variables had low t-statistic p-values, and the overall p-value of the F-statistic of the
model was low, too. The same occurs with Model 2, which regards the cost range of
$600.01 - $1800.00. The Summary of Fit, the Analysis of Variance, and the
Parameter Estimates report of Model 2 are given in Figure 30.
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Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.027174
0.025323
293.2935
994.4549
5791

Analysis of Variance
Source
Model
Error
C. Total

DF
11
5779
5790

Sum of Squares
13886220
497115830
511002049

Mean Square
1262384
86021

F Ratio
14.6753
Prob > F
<.0001*

Parameter Estimates
Term
Intercept
ENLISTED
O1,O2,O3
O4,O5,O6
DUMMY FOR DISEASE 1
DUMMY FOR DISEASE 10
DUMMY FOR DISEASE 2
DUMMY FOR DISEASE 8
E5,E6
DUMMY FOR DISEASE 11
GENDER_1
O7,O8,O9,O10

Estimate
924.52264
102.28975
107.45701
69.116268
-39.79508
-115.4091
-41.32374
-153.7974
22.610802
-74.36178
27.247629
163.22885

Std Error t-ratio Prob>|t|
VIF
18.2785 50.58 0.0000*
.
12.37734 8.26 <.0001* 2.393883
19.77797 5.43 <.0001* 1.3301553
14.08404 4.91 <.0001* 1.9318035
13.49212 -2.95 0.0032* 3.0627137
29.61618 -3.90 <.0001* 1.1884551
14.14094 -2.92 0.0035* 2.8695385
25.99338 -5.92 <.0001* 1.2590722
9.804203 2.31 0.0211* 1.2787366
20.83754 -3.57 0.0004* 1.4674738
11.44658 2.38 0.0173* 1.0622896
62.16223 2.63 0.0087* 1.0290769

Figure 30: Summary of Fit, Analysis of Variance and Parameter Estimates for
Cost range $600.01-$1800.00
This model appears to have even lower predictability than Model 1. The R2
value equals to 0.0272, and this means that the model explains approximately 2.72%
of the variation in the dependent variable. The overall p-value of the F-statistic is
lower than 0.05 and thus the null hypothesis that the explanatory variables in the
model are not effective is rejected. The predictive variables of this model with low tstatistic p-values are: ENLISTED, O1-O2-O3, O4-O5-O6, O7-O8-O9-O10, E5-E6,
GENDER_1 and the Dummy Variables for Diseases 1, 2, 8, 10 and 11. Disease 1
refers to Ischemic Heart Disease, disease 2 refers to Cerebrovascular disease, disease
8 refers to Bronchitis, Emphysema, disease 10 refers to Other Arterial disease and
disease 11 refers to the rest of the most prevalent diseases related to smoking, which
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are presented in a detailed way in Table 15. The OLS regression model for the cost
range of $600.01 - $1800.00 is given by the formula below:

Cost=924.52+102.29*(ENLISTED)+107.46*(O1,O2,O3)+69.12*(O4,O5,O6)
+ 163.23*(O7,O8,O9,O10)+22.61*(E5,E6)+27.25*(GENDER_1)39.80*(Ischemic Heart Disease)-41.32*(Celebrovascular Disease)153.80*(Bronchitis, Emphysema)-115.41*(Other Arterial disease)74.36*(Other Diseases)

The VIF scores of all the variables are below 5 and the model does not have
any influential points, as shown in Cook’s Distance Overlay Plot in Appendix C. In
addition, the model does not pass the Shapiro-Wilk test for normality and the
Breusch-Pagan test for constant variance.
Data Set 3 – Cost Range $1,800.01 - $11,000.00 – Model 3
The third model concerns the data set of cost range $1800.01-$11,000.00 and
the Summary of Fit, the Analysis of Variance, and the Parameter Estimates report are
given below in Figure 31.
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Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.008385
0.007316
2443.441
4578.227
2785

Analysis of Variance
Source
Model
Error
C. Total

DF
3
2781
2784

Sum of Squares
140406398
1.6604e+10
1.6744e+10

Mean Square
46802133
5970403.4

F Ratio
7.8390
Prob > F
<.0001*

Parameter Estimates Report
Term
Estimate Std Error t-ratio Prob>|t|
VIF
Intercept
4835.6026 83.45806 57.94 <.0001*
.
AGE 25-34
-300.8502 134.2686 -2.24 0.0251* 1.0018253
ENLISTED
-281.2203 98.99104 -2.84 0.0045* 1.0066894
DUMMY FOR DISEASE 7 -951.7804 281.3771 -3.38 0.0007* 1.0053827

Figure 31: Summary of Fit, Analysis of Variance and Parameter Estimates for
Cost range $1,800.01-$11,000.00

This model appears to have the lowest R-Squared and Adjusted R-Squared
values, which means that the predictability of the model is very low. The R-Square
equals to 0.008385, indicating that this model explains approximately 0.8385% of the
variation in the dependent variable. This occurs because there is a lot of variability in
the data, not explained by the model. The p-value of the F-statistic, which determines
the overall statistical significance of the model, is very low. The p-values of the tstatistic of each explanatory variable are lower than 0.05 and the VIF scores of all of
them are lower than 5. The most predictive variables for this cost range are: AGE 2534, ENLISTED and the Dummy Variable for disease 7, which is the Malignant
Neoplasms of Urinary Bladder. The equation of this model is given by the following
formula:
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Cost=4835.60-300.85*(AGE 25-34)-281.22*(ENLISTED)-951.78*(Malignant
Neoplasms of Urinary Bladder)

The model does not appear to have any influential points, according to Cook’s
Distance Overlay plot, graphed in Appendix C. This model, like the previous ones,
does not pass the tests for Normality and Constant Variance.

Data Set 4 – Cost Range $11,000.01 - $30,000.00 – Model 4
Model 4 regards the cost range of $11,000.01-$30,000.00 and the results of the
Summary of Fit, the Analysis of Variance, and the Parameter Estimates Report, are
presented below in Figure 32.

Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.013927
0.011433
4978.371
17518.16
794

Analysis of Variance
Source DF Sum of Squares Mean Square F Ratio
Model
2
276876512
138438256 5.5858
Error
791
1.9604e+10
24784176 Prob > F
C. Total 793
1.9881e+10
0.0039*

Parameter Estimates
Term
Estimate Std Error t-ratio Prob>|t|
VIF
Intercept
17958.049 259.8688 69.10 <.0001*
.
O7,O8,O9,O10 6105.6255 2885.988 2.12 0.0347* 1.0043652
AGE 35-44
-866.9508 354.9437 -2.44 0.0148* 1.0043652

Figure 32: Summary of Fit, Analysis of Variance and Parameter Estimates for
Cost range $11,000.01-$30,000.00
The R2 value of this model equals 0.013927, indicating that the predictability
of the model equals 1.3927%. The F-statistic appears to have a p-value lower than
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0.05 and the cost in this model is predicted by two variables, which are O7-O8-O9O10 and AGE 35-44. The VIF scores of the regressors are below 5. The model is
given by the following equation:

Cost=17958.05+6105.63*(O7-O8-O9-O10)-866.95*(AGE 35-44)

The Cook’s Distance Overlay plot, presented in Appendix B, does not graph
any influential points, but the model does not pass the tests for Normality and
Constant Variance.

Data Set 5 – Cost Range $30,000.01 - $307,064.00 – Model 5
The last model concerns the extremely high cost range of $30,000.01$307,064.00 and its Actual by Predicted plot, Summary of Fit, Analysis of Variance,
and Parameter Estimates Report are given in Figure 33.
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Actual by Predicted Plot

Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.175222
0.164273
32535.54
55917.78
230

Analysis of Variance
Source
Model
Error
C. Total

DF
3
226
229

Sum of Squares
5.0825e+10
2.3923e+11
2.9006e+11

Mean Square
1.694e+10
1.0586e+9

F Ratio
16.0044
Prob > F
<.0001*

Parameter Estimates
Term
Intercept
E1,E2,E3,E4
AGE 45-60
DUMMY FOR DISEASE 2

Estimate
39587.422
18783.413
14670.658
27735.602

Std Error t-ratio Prob>|t|
VIF
3381.55 11.71 <.0001*
.
7431.762 2.53 0.0122* 1.0800354
4695.764 3.12 0.0020* 1.0930497
4669.303 5.94 <.0001* 1.0549758

Figure 33: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and
Parameter Estimates for Cost range $30,000.01-$307,064.00

Compared to the previous four models, this model is the one, with the highest
R2 and Adjusted R2 values. The R2 value equals 0.175222, which means the model
explains 17.5222% of the variation in the dependent variable. The p-value of the Fstatistic is very low and lower than 0.05 and all the predictive variables have p-values
of the t-statistic lower than 0.05 and VIF scores below 5. The regressors of this model
are: E1-E2-E3-E4, AGE 45-60 and the Dummy Variable for disease 2, which is
Cerebrovascular Disease. The equation of the model is the following:
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Cost=39587.42+18783.41*(E1,E2,E3,E4)+14670.66*(AGE 4560)+27735.60*(Celebrovascular Disease)

The Actual by Predicted Plot (See Figure 33) shows two potential influential points
and the same can be seen from the Cook’s Distance Overlay Plot, given below in
Figure 34.

Figure 34: Cook’s Distance Overlay Plot for Model 5

These two influential points correspond to the two extreme cost values of
$252,301 and $307,063, which lie far enough from the rest of the values of this cost
range. Subsequently, these two values must be removed and the model must be reassessed and re-examined for its validity and predictability, excluding these two
influential points. The Actual by Predicted Plot, the Summary of Fit, the Analysis of
Variance, and the Parameter Estimates Report of the new re-assessed model are given
in Figure 35.
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Actual by Predicted Plot

Summary of Fit
RSquare
RSquare Adj
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.171248
0.160148
26341.24
53954.94
228

Analysis of Variance
Source
Model
Error
C. Total

DF
3
224
227

Sum of Squares
3.2116e+10
1.5542e+11
1.8754e+11

Mean Square
1.071e+10
693861153

F Ratio
15.4286
Prob > F
<.0001*

Parameter Estimates
Term
Intercept
E1,E2,E3,E4
DUMMY FOR DISEASE 2
AGE 45-60

Estimate
42114.882
20085.721
20959.856
8424.9607

Std Error t-ratio Prob>|t|
VIF
2747.569 15.33 <.0001*
.
6018.051 3.34 0.0010* 1.0794089
3831.182 5.47 <.0001* 1.0646598
3844.763 2.19 0.0295* 1.0998795

Figure 35: Actual by Predicted Plot, Summary of Fit, Analysis of Variance and
Parameter Estimates, excluding the Influential Points

The new model, excluding the influential points, has not changed that much.
Its predictability, according to the R2 value, is 17.1248% and the p-values of the F and
the t-statistic remain lower than 0.05. The VIF scores of the regressors are below 5.
The new model does not pass the Shapiro-Wilk test of Normality. The results of this
test are presented in Figure 36.
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Studentized Residuals COST

Parameter Estimates
Type
Parameter Estimate Lower 95% Upper 95%
Location µ
-8.119e-5 -0.131208 0.1310453
Dispersion σ
1.0048196 0.9202783 1.1065984
-2log(Likelihood) = 648.228417495289

Goodness-of-Fit Test
Shapiro-Wilk W Test
W
0.887470

Prob<W
<.0001*

Figure 36: Shapiro-Wilk Test for Normality for the re-assessed model
The model does not pass the Breusch-Pagan test either. The results of the BreuschPagan test are given by Table 26.

Table 26: Breusch-Pagan test for the re-assessed model

SSR
SSE
N
df
(reg)

Input
5.02E+1
9
1.55E+1
1
228

Test
Stat

54.00829

P-value 1.12E-11

3

The re-assessed model, excluding the two influential points, explains almost
the same variation of the dependent variable as model 5 does. Even though this last
model yields the highest predictability, compared to the other four, it still cannot be

107

used to predict and explain the variation of cost, since there is a lot of variability in
the data left unexplained. Notwithstanding, all the models developed above, provide
valuable information about which factors could affect the cost of hospitalization.
Summary
This chapter presented the results of the Contingency Analysis, the Pivot
Table Analysis, and the Regression Analysis. The Contingency Analysis proved the
existence of relationship between smoking and pay rank, gender and age.
Furthermore, it enriched this study with graphs and informative percentages of the
smoking status of each group of smokers, among the ADAF personnel. The Pivot
Table Analysis focused on the cost of hospitalization of the ADAF members because
of smoking related diseases, and provided meticulous information about the total and
average cost of hospitalization for each year and for several groups with different
socio-demographic characteristics. Finally, the same data set of cost was used, in
order to explore the statistical relationship between cost and several variables related
to socio-demographic characteristics of the ADAF population and to the most
prevalent diseases related to smoking.
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V. Conclusions
Overview
This chapter uses the results of Chapter IV to answer the research questions
initially proposed in Chapter I. After the assessment of the questions, an appraisal of
the strengths and limitations of this study will be presented. This chapter closes with
possible follow-up suggestions for further analysis in future studies.
Findings
In Chapter I, three research questions were defined, with research question
number one was partitioned in three sub questions. After accomplishing a literature
review and defining the methodology used in this study, two data sets were used with
different tools, in order to analyze and answer the research questions, which are the
object of this study research. The answers of all the research questions were based on
the results of the previous chapter.
Research Question 1: How is smoking affected by the socio-demographic
characteristics of the ADAF population?
• How smoking is affected by pay rank?
• How smoking is affected by gender?
• How smoking is affected by age?
This research question was answered after the analysis of the Web HA data
set, with the aid of the Contingency Analysis tool. The Mosaic Plots, the
Contingency Tables, and the Tests Reports were the products of the Contingency
Analysis and demonstrated visually and statistically the existence of a relationship
between smoking and pay rank, gender, and age. The Tests Reports of all three
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Contingency Analyses developed in Chapter IV each reported very low Likelihood
Ratio and Pearson p-values, which indicate a relationship between smoking and the
socio-demographic characteristics of pay rank, gender, and age. Furthermore, the
percentages of the contingency tables were used in Microsoft Excel® for a visual
portrayal of the smoking status of Air Force, based on pay rank, gender and age.
More specifically, regarding the subquestion ‘How is smoking affected by pay
rank’, the analysis showed that the majority of smokers among the ADAF personnel
consists of enlisted personnel. First, the Contingency Analysis demonstrated that
48.64% of the whole Air Force population smokes, which is a remarkably high
percentage. This percentage is the result of the Contingency Analysis done with the
usage of the AF Web HA data set. The percentage of 48.64% regards the active duty
personnel that have used any kind of tobacco products in their entire life. That means
that 48.64% of the active duty personnel have smoked at least 100 cigarettes or used
any other type of tobacco product at least 20 times in their entire life. Second,
according to the previously stated information that the majority of smokers are
enlisted, 48.64% of smokers, analyzed further, is comprised of 42.46% of enlisted and
6.17% of officers. Lastly, 52.41% of the enlisted population is smokers, which
suggests negative consequences for the quality and readiness of this population.
There are more males in the Air Force than females and this fact helps answer
the subquestion “How is smoking affected by gender”. The percentage of 48.64% of
smokers, if partitioned further under the criteria of gender, is comprised of 40.84%
male and 7.79% female smokers. Additionally, if smokers are considered a population
of their own, this population consists of 83.98% men and 16.02% women, and this
fact underscores the prevalence of smoking among men in the Air Force.
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The final subquestion of the first research question examines the relationship
between smoking and age. It is shown in this research that almost every age group is
nearly equally divided into two groups: smokers and non-smokers. In some age
groups smokers are the majority, such as in the age groups 17-24 and 25-29. If the
percentage 48.64% is broken up into age groups, the 13.94% belongs to the age group
17-24, 12.08% to the age group 25-29 (among these two age groups, smoking is most
prevalent), 7.85% to the age group 30-34, 6.59% to the age group 36-39, and 8.18% to
the group over 40.
All the above results which correlate smoking with pay rank, gender and age,
should be used to better target smoking cessation programs and policies. The answer
to the first research question verifies that smoking is more prevalent among the
enlisted, males, and the young age groups. Half the enlisted population smokes. 83%
of the smoking population is males. The age groups of 17-24 and 25-29 are the groups
that smoke more.
Research Question 2: Which diseases cost more to the U.S. Air Force,
according to their total cost of hospitalization?
The second research question was answered through the analysis of a different
set of data than that of the first question. For the second research question, the data set
of the cost of hospitalization of ADAF personnel because of smoking related diseases
was used and analyzed with the assistance of Microsoft Excel, and particularly with
the Pivot Tables tool. The most important product of this analysis was the list with the
most prevalent diseases related to smoking with the highest cost. This list is given
below in Table 27.
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Table 27: List of the Most Prevalent Diseases Related to Smoking
with the Highest Cost
ISCHEMIC HEART DISEASE
CEREBROVASCULAR DISEASE
MALIGNANT NEOPLASMS OF TRACHEA, LUNG, BRONCHUS
MALIGNANT NEOPLASMS OF LIP, ORAL, CAVITY, PHARYX
OTHER HEART DISEASE
MALIGNANT NEOPLASMS OF KIDNEY AND RENAL PELVIS
MALIGNANT NEOPLASMS OF URINARY BLADDER
BRONCHITIS, EMPHYSEMA
MALIGNANT NEOPLASMS OF PANCREAS
OTHER ARTERIAL DISEASE
OTHERS

1
2
3
4
5
6
7
8
9
10
11

The above table helps answer the second research question, but the
manipulation of the data, in the process of answering the second research question,
produced numerous results and outcomes. The Pivot Tables showed that the grand
total cost of hospitalization for the period 1999-2009 was $49,193,334, where
$43,013,308 concerned the male population of the Air Force and $6,180,026 the
female population of the Air Force. Furthermore, the grand average cost (the
definition “grand” refers to the period 1999-2009) for males was $1,774 and for
females $1,480, indicating that the gap of average cost for both genders is not large
and cost might not be affected by gender. Of importance is that the age groups with
the highest grand total cost were the groups of 33-40 and 41-48 years. In addition, the
groups with the highest grand average cost were the age groups 41-48, 49-56, and 5764 years old. Supplementary information to the statistical analysis, regarding the age
groups, is that groups 33-40 and 41-48 years old were the groups with the highest
grand total number of visits to hospital or doctor. All this information, combined with
the previous Contingency Analysis of the correlation between smoking and age,
provides significant evidence that smoking is most prevalent among the young ages of
17 to 29, while the cost consequences of smoking are apparent in the older age groups
of 33 to 48. A preventive anti-smoking policy, mostly focused on the younger ages
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when people start smoking, could reduce the number of future smokers and save a
considerable part of the Air Force budget spent on medical expenses related to
smoking.
The outcome of the analysis of the frequency of visits to the hospital or to the
doctor, due to a disease related to smoking, generated another list of diseases. In this
list, the diseases were sorted by their frequency of appearance in the Primary
Diagnosis column. Ischemic heart disease and cerebrovascular disease were the top
two diseases, while being the diseases with the highest cost. This validates that these
two diseases are the most prevalent diseases related to smoking. Finally, it is
worthwhile to mention that the largest part of the grand total medical expenses of the
Air Force related to smoking was due to the enlisted population. During the period
1999-2009, $33,571,520 was spent for the hospitalization of enlisted personnel and
$15,621,813 was spent for the hospitalization of officers. The pattern of the grand
average cost for each pay rank is reversed, with the grand average cost of enlisted was
$1,590 and of the officers $2,135. Additionally, the general grand average cost of
hospitalization for the whole Air Force population was $1,731.
The answer of the second research question revealed that the most prevalent
diseases related to smoking are ischemic heart disease and cerebrovascular disease.
Moreover, the largest portion of the medical expenses related to hospitalization
corresponds to the enlisted population and the age range 33 to 48. Furthermore,
smoking is most prevalent among men. All these conclusions could compose the main
targets of a future, more effective anti-smoking campaign and of a beneficiary
research for the shrinkage of the medical expenses of the ADAF personnel, related to
smoking.
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Research Question 3: How is the cost of hospitalization affected by
gender, age, pay rank and each disease separately?
The third research question of this study was answered through the analysis of
the same cost data set used in research question two. The tool used for the analysis of
the data set and for answering the third question was the Regression Analysis, with
the aid of JMP. Five models were developed, for five subsets of different cost range,
in order to detect a relationship between cost and gender, age, pay rank, and the most
prevalent diseases related to smoking with the highest cost. All five models generated
low R2 and low Adjusted R2 values, meaning that the whole predictability of the
models was of minimal importance. There was a lot of variability in the data set, not
explained by the models, and for this reason the models did not provide a good fit for
the variables with the data. The overall p-value of the F-statistic for all five models
was very low, allowing the rejection of the null hypothesis that the explanatory
variables are not effective and indicating that the explanatory variables are statistically
related to the dependent variable. The same result occurred with the p-values of the tstatistic of each variable used in the models. All the variables resulted in low p-values
and VIF scores below 5. The variables used more than one time in the five models
developed in the Regression Analysis, are: AGE 45-60, ENLISTED, O1-O2-O3, O4O5-O6, O7-O8-O9-O10, Ischemic Heart Disease, Cerebrovascular Disease, Malignant
Neoplasms of Urinary Bladder, and Other Arterial Disease. These variables have
greater effect and better explain the cost of hospitalization. The age that affects cost
the most is 45- 60 years old. All the pay grades of officers explain and affect the cost
more than the pay grades of enlisted. This might be due to the higher average cost of
officers, shown in the Pivot Table analysis. The diseases that affect cost more are the
diseases numbered 1, 2, 7 and 10 of the list (See Table 27) of the most prevalent
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diseases related to smoking with the highest cost. These diseases correspond to
Ischemic Heart Disease, Cerebrovascular Disease, Malignant Neoplasms of Urinary
Bladder and Other Arterial Disease. The Regression Analysis proved that the two
diseases with the highest cost and with the highest frequency of visits, Ischemic Heart
Disease and the Cerebrovascular Disease, are the diseases that affect cost most, and
can be used as explanatory variables of cost.

Strengths and Limitations
According to the research questions defined in Chapter I, this study tried to
detect the existence of a relationship between smoking and several socio-demographic
characteristics associated with the Air Force population, to present the status of
smoking among the ADAF personnel, to investigate the factors that affect the cost of
hospitalization due to smoking related diseases, and to examine which variables could
be the most explanatory ones for the prediction of this cost. The various methods used
for the investigation of the research questions and the results returned from the
analysis, showed the strengths and the limitations of this study.
One of the strengths of this study is the fact that the Contingency Analysis
proved the existence of a strong relationship between smoking and pay rank, gender
and age. Moreover, this kind of analysis enriched the study with information and
graphs about the smoking status of the ADAF personnel. A second strength of this
research is for the findings regarding the assortment of diseases by their total cost and
their frequency of visits during the period 1999-2009. This classification was used in
the Regression Analysis for the creation of dummy variables, associated with the
diseases, which were later used for the development of the OLS linear models.
Furthermore, the Pivot Table Analysis enhanced the informative status of this study
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about the cost of smoking, generating percentages and graphs associated with the total
and average cost of each socio-demographic group of the U.S. Air Force. This type of
analysis showed that the grand total cost of enlisted was much higher than the grand
total cost of officers, but the grand average cost of officers was higher than the grand
average cost of enlisted.

This piece of information was confirmed later in the

Regression Analysis, where the pay grades of officers were among the explanatory
factors of the cost.
The study is limited as the OLS linear models, developed in the Regression
Analysis, do not guarantee predictability, and likely cannot be used for future
research. The variability, spread in the data, did not permit a good fit of the variables
with the data. Nevertheless, the five models developed gave a number of variables
that could be used in the future as explanatory variables of cost, in different data sets
with lower variability. Even though the predictability of the models is very low and
the models do not explain at a satisfactory level the variation in the cost, the same
models demonstrated that the variables used as explanatory variables, include
Ischemic Heart Disease, Cerebrovascular Disease, the age group of 45-60, and the pay
grades of officers, which are variables shown to affect the cost in the Pivot Table
Analysis as well. Underneath the Regression Analysis of this study there is strength,
limited by the low predictability of the models.

Follow-Up Suggestions for Further Research
Opportunities for further research include the investigation of the average cost
of officers. The Pivot Table Analysis revealed that the grand total cost of enlisted is
remarkably higher, compared to the cost of the officers. On the other hand, the grand
average cost of officers seems to be noticeably higher compared to the cost of
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enlisted. Moreover, in the Regression Analysis it was shown that, among the
explanatory variables of the cost, there was a variable referencing enlisted and
variables associated with all the pay grades of officers. This fact proves that enlisted
affect the total cost, but officers affect the average cost. The further research here lies
in investigating the factors that influence the average cost of officers and render it
higher compared to the one of enlisted.
Other research efforts should be directed at comparing the results of this study
with analogous studies, elaborated in the other armed forces of the U.S. military.
Identifying differences in the explanatory factors of cost and in the classification of
the most prevalent diseases related to smoking with the rest of the armed forces, could
grant a better and more scrupulous portrait of the smoking status of the Air Force.
Summary
Smoking is a social phenomenon and nowadays is characterized as an
epidemic. It likely affects people of every race and social status. Smoking has become
an alarming issue for the U.S. Air Force since, as demonstrated in this study, almost
half the population of the ADAF personnel smokes. This study examined the
association of smoking status and cost, provoked by smoking, with several sociodemographic characteristics of the Air Force population. These results could be used
in the future, for a more effective and focused on specific groups, smoking cessation
campaign and policy, for eliminating the smoking phenomenon and improving the
quality of health, productivity, and readiness of the U.S. Air Force personnel.
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Appendix A. AF Web HA Data Dictionary – Tobacco-Use section

SECTION 8: TOBACCO USE

Q8_1a

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T1

Question: In your entire life, have you?
(Check all that apply) Smoked at least
one hundred cigarettes?

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” Smoked at least one hundred cigarettes?

Value:
1

Description:
Checked - Smoked at least one hundred cigarettes?

Q8_1b

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T1

Question: In your entire life, have you?
(Check all that apply) Smoked a pipe at
least 20 times?

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” Smoked a pipe at least 20 times?

Value:
1

Description:
Checked - Smoked a pipe at least 20 times?

Q8_1c

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T1

Question: In your entire life, have you?
(Check all that apply) Smoked a cigar at
least 20 times?

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” Smoked a cigar at least 20 times?

Value:
1

Description:
Checked - Smoked a cigar at least 20 times?

Q8_1d

Type: Numeric
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Qcode: T1

Section Number: 8-Tobacco Use

Question: In your entire life, have you?
(Check all that apply) Used chewing
tobacco or snuff at least 20 times?

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” Used chewing tobacco or snuff at least 20
times?

Value:
1

Description:
Checked - Used chewing tobacco or snuff at least 20 times?

Q8_1e

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T1

Question: In your entire life, have you?
(Check all that apply) I only use tobacco
products occasionally

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” I only use tobacco products occasionally

Value:
1

Description:
Checked - I only use tobacco products occasionally

Q8_1f

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T1

Question: In your entire life, have you?
(Check all that apply) I have never used
tobacco products

Description:

Derived from question: “In your entire life, have you? (Check
all that apply)” I have never used tobacco products

Value:
1

Description:
Checked - I have never used tobacco products

Q8_2a

Type: Numeric

Section Number: 8-Tobacco Use

Description:

Qcode: T2

Question: Do you currently use any of
the following tobacco products? (Check
all that apply) Cigarettes

Derived from question: “Do you currently use any of the
following tobacco products? (Check all that apply)” Cigarettes.
(Asked if Q8_1f NE 1).
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Value:
1

Q8_2b

Description:
Checked - Cigarettes

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T2

Question: Do you currently use any of
the following tobacco products? (Check
all that apply) Pipe

Description:

Derived from question: “Do you currently use any of the
following tobacco products? (Check all that apply)” Pipe.
(Asked if Q8_1f NE 1).

Value:
1

Description:
Checked - Pipe

Q8_2c

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T2

Question: Do you currently use any of
the following tobacco products? (Check
all that apply) Cigars

Description:

Derived from question: “Do you currently use any of the
following tobacco products? (Check all that apply)” Cigars.
(Asked if Q8_1f NE 1).

Value:
1

Description:
Checked - Cigars

Q8_2d

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T2

Question: Do you currently use any of
the following tobacco products? (Check
all that apply) Chewing tobacco or snuff

Description:

Derived from question: “Do you currently use any of the
following tobacco products? (Check all that apply)” Chewing
tobacco or snuff. (Asked if Q8_1f NE 1).

Value:
1

Description:
Checked - Chewing tobacco or snuff

Q8_2e

Type: Numeric
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Qcode: T2

Section Number: 8-Tobacco Use

Question: Do you currently use any of
the following tobacco products? (Check
all that apply) None of the above

Description:

Derived from question: “Do you currently use any of the
following tobacco products? (Check all that apply)” None of
the above. (Asked if Q8_1f NE 1).

Value:
1

Description:
Checked - None of the above

Q8_3

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T3a

Question: Do you now smoke
cigarettes?

Description:

Response to question: “Do you now smoke cigarettes?” (Asked
if Q8_2a = 1).

Value:
1
2

Description:
Smoke cigarettes every day
Smoke cigarettes on some days

Q8_4

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T7

Question: About how long ago was it
that you started smoking cigarettes?

Description:

Response to question: “About how long ago was it that you
started smoking cigarettes?” (Asked if Q8_3 = 1).

Value:
1
2
3
4
5
6
9

Description:
Less than 1 month ago
1 month but less than 3 months ago
3 months but less than 6 months ago
6 months but less than 12 months ago
1 year but less than 5 years ago
More than 5 years ago
Don't know / Not sure

Q8_5

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T8

Question: All together, for how many
years have you been a regular smoker,
not including the years that you had quit?
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Description:

Response to question: “All together, for how many years have
you been a regular smoker, not including the years that you had
quit?” (Asked if Q8_4 = 5 or 6).

Value:
1
2
3
4
5
6
9

Description:
1-2 years
3-5 years
6-10 years
11-15 years
16-20 years
More than 20 years
Don't know / Not sure

Q8_6

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T9

Question: On the average, how many
cigarettes do you now smoke per day?

Description:

Response to question: “On the average, how many cigarettes do
you now smoke per day?” (Asked if Q8_3 = 1).

Value:
1
2
3
4
5
6
9

Description:
Less than 1 cigarette a day
1-10 cigarettes a day (half a pack)
11-20 cigarettes a day (1 pack)
21-30 cigarettes a day (1 and a half packs)
31-40 cigarettes a day (2 packs)
More than 40 cigarettes a day (more than 2 packs)
Don't know / Not sure

Q8_7

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T10

Question: Which best describes your
intentions regarding quitting smoking?

Description:

Response to question: “Which best describes your intentions
regarding quitting smoking?” (Asked if Q8_3 = 1).

Value:
1

Description:
I intend to quit in the next 30 days and have tried for at least 24
hours in the past year
I intend to quit in the next 30 days
I intend to quit in the next 6 months
I do not intend to quit in the next 6 months

2
3
4

Q8_8

Type: Numeric
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Qcode: T11

Section Number: 8-Tobacco Use

Question: About how long ago was it
that you started smoking cigarettes?

Description:

Response to question: “About how long ago was it that you
started smoking cigarettes?” (Asked if Q8_3 = 2).

Value:
1
2
3
4
5
6
9

Description:
Less than 1 month ago
1 month but less than 3 months ago
3 months but less than 6 months ago
6 months but less than 12 months ago
1 year but less than 5 years ago
More than 5 years ago
Don't know / Not sure

Q8_9

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T12

Question: All together, for how many
years have you smoked cigarettes, not
including the years that you have quit?

Description:

Response to question: “All together, for how many years have
you smoked cigarettes, not including the years that you have
quit?” (Asked if Q8_8 = 5 or 6).

Value:
1
2
3
4
5
6
9

Description:
1-2 years
3-5 years
6-10 years
11-15 years
16-20 years
More than 20 years
Don't know / Not sure

Q8_10

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T13

Question: On the average, when you
smoked during the past 30 days, about
how many cigarettes did you smoke each
day?

Description:

Response to question: “On the average, when you smoked
during the past 30 days, about how many cigarettes did you
smoke each day?” (Asked if Q8_3 = 2).

Value:

Description:
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1
2
3
4
5
6
9

Q8_11

Less than 1 cigarette a day
1-10 cigarettes a day (half a pack)
11-20 cigarettes a day (1 pack)
21-30 cigarettes a day (1 and a half packs)
31-40 cigarettes a day (2 packs)
More than 40 cigarettes a day (more than 2 packs)
Don't know / Not sure

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T14

Question: On how many of the past 30
days did you smoke cigarettes?

Description:

Response to question: “On how many of the past 30 days did
you smoke cigarettes?” (Asked if Q8_3 = 2).

Value:
1
2
3
4
5
6
9

Description:
1-5 days
6-10 days
11-15 days
16-20 days
21-25 days
26-30 days
Don't know / Not sure

Q8_12

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T15

Question: Which best describes your
intentions regarding quitting smoking?

Description:

Response to question: “Which best describes your intentions
regarding quitting smoking?” (Asked if Q8_3 = 2).

Value:
1

Description:
I intend to quit in the next 30 days and have tried for at least 24
hours in the past year
I intend to quit in the next 30 days
I intend to quit in the next 6 months
I do not intend to quit in the next 6 months

2
3
4

Q8_13

Type: Numeric

Section Number: 8-Tobacco Use
Description:

Qcode: T3b

Question: Do you now smoke a pipe?

Response to question: “Do you now smoke a pipe?” (Asked if
Q8_2b = 1).
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Value:
1
2

Q8_14

Description:
Smoke a pipe every day
Smoke a pipe on some days

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T18AF

Question: Which best describes your
intentions regarding quitting smoking a
pipe?

Description:

Response to question: “Which best describes your intentions
regarding quitting smoking a pipe?” (Asked if Q8_2b = 1).

Value:
1

Description:
I intend to quit in the next 30 days and have tried for at least 24
hours in the past year
I intend to quit in the next 30 days
I intend to quit in the next 6 months
I do not intend to quit in the next 6 months

2
3
4

Q8_15

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T3c

Question: Do you now smoke cigars?

Description:

Response to question: “Do you now smoke cigars?” (Asked if
Q8_2c = 1).

Value:
1
2

Description:
Smoke cigars every day
Smoke cigars on some days

Q8_16

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T19af

Question: Which best describes your
intentions regarding quitting smoking
cigars?

Description:

Response to question: “Which best describes your intentions
regarding quitting smoking cigars?” (Asked if Q8_2c = 1).

Value:
1

Description:
I intend to quit in the next 30 days and have tried for at least 24
hours in the past year
I intend to quit in the next 30 days
I intend to quit in the next 6 months

2
3
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4

Q8_17

I do not intend to quit in the next 6 months

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T3d

Question: Do you now use chewing
tobacco or snuff?

Description:

Response to question: “Do you now use chewing tobacco or
snuff?” (Asked if Q8_2d = 1).

Value:
1
2

Description:
Use chewing tobacco or snuff every day
Use chewing tobacco or snuff on some days

Q8_18

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T16

Question: About how long ago was it
that you started using chewing tobacco
or snuff regularly?

Description:

Response to question: “About how long ago was it that you
started using chewing tobacco or snuff regularly?” (Asked if
Q8_2d = 1).

Value:
1
2
3
4
5
6
9

Description:
Less than 1 month ago
1 month but less than 3 months ago
3 months but less than 6 months ago
6 months but less than 12 months ago
1 year but less than 5 years ago
More than 5 years ago
Don't know / Not sure

Q8_19

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T17

Question: On the average, when you
smoked during the past 30 days, about
how many cigarettes did you smoke each
day?

Description:

Response to question: “On the average, when you smoked
during the past 30 days, about how many cigarettes did you
smoke each day?” (Asked if Q8_2d = 1).

Value:
1

Description:
Less than 1 time a day
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2
3
4
5
6
9

Q8_20

1-2 times a day
3-5 times a day
6-10 times a day
11-20 times a day
More than 20 times a day
Don't know / Not sure

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T17aAF

Question: Which best describes your
intentions regarding quitting smokeless
tobacco (chewing tobacco or snuff)?

Description:

Response to question: “Which best describes your intentions
regarding quitting smokeless tobacco (chewing tobacco or
snuff)?” (Asked if Q8_2d = 1).

Value:
1

Description:
I intend to quit in the next 30 days and have tried for at least 24
hours in the past year
I intend to quit in the next 30 days
I intend to quit in the next 6 months
I do not intend to quit in the next 6 months

2
3
4

Q8_21

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T4

Question: About how long has it been
since you last smoked cigarettes?

Description:

Response to question: “About how long has it been since you
last smoked cigarettes?” (Asked if Q8_1a = 1 and Q8_2e=1).

Value:
1
2
3
4
9

Description:
Less than 1 month ago
1 month but less than 3 months ago
3 months but less than 6 months ago
6 months ago or more
Don't know / Not sure

Q8_22

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T5

Question: During the years that you
smoked, about how many cigarettes per
day did you smoke?

127

Description:

Response to question: “During the years that you smoked,
about how many cigarettes per day did you smoke?” (Asked if
Q8_1a = 1 and Q8_2e=1).

Value:
1
2
3
4
5
6
9

Description:
Less than 1 cigarette a day
1-10 cigarettes a day (half a pack)
11-20 cigarettes a day (1 pack)
21-30 cigarettes a day (1 and a half packs)
31-40 cigarettes a day (2 packs)
More than 40 cigarettes a day (more than 2 packs)
Don't know / Not sure

Q8_23

Type: Numeric

Section Number: 8-Tobacco Use

Qcode: T6

Question: All together, for how many
years did you smoke cigarettes, not
including the years that you had quit?

Description:

Response to question: “All together, for how many years did
you smoke cigarettes, not including the years that you had
quit?” (Asked if Q8_1a = 1 and Q8_2e=1).

Value:
1
2
3
4
5
6
7
9

Description:
Less than 1 year
1-2 years
3-5 years
6-10 years
11-15 years
16-20 years
More than 20 years
Don't know / Not sure

Q8_24

Type: Numeric

Qcode: T24AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: During the past 12 months,
have you stopped the use of any tobacco
products for one day or longer because
you were trying to quit?

Description:

Response to question: “During the past 12 months, have you
stopped the use of any tobacco products for one day or longer
because you were trying to quit?” (Asked if Q8_1f ne 1).

Value:

Description:
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1
2

Yes
No

Q8_25

Type: Numeric

Qcode: T25AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products for one day or
longer, did you do anything to assist you
with quitting?

Description:

Response to question: “When you last stopped the use of
tobacco products for one day or longer, did you do anything to
assist you with quitting?” (Asked if Q8_24 = 1).

Value:
1
2

Description:
Yes
No

Q8_26a

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) Consulted with (non-HAWC)
Doctor, Nurse, or other health
professional

Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) Consulted with (non-HAWC)
Doctor, Nurse, or other health professional” (Asked if Q8_25 =
1).

Value:
1

Description:
Checked - Consulted with (non-HAWC) Doctor, Nurse, or
other health professional

Q8_26b

Type: Numeric

ADDED 10/31/2008
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Qcode: T26AF

Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) Medication such as nicotine gum,
patch, nasal spray, inhaler, lozenge, or
prescription medication

Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) Medication such as nicotine
gum, patch, nasal spray, inhaler, lozenge, or prescription
medication” (Asked if Q8_25 = 1).

Value:

Description:
Checked - Medication such as nicotine gum, patch, nasal spray,
inhaler, lozenge, or prescription medication

1

Q8_26c

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) Class

Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) Class” (Asked if Q8_25 = 1).

Value:

Description:
Checked - Class

1

Q8_26d

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Description:

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) Call-line

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) Call-line” (Asked if Q8_25 =
1).
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Value:
1

Description:
Checked – Call-line

Q8_26e

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) One-on-one session with HAWC
staff

Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) One-on-one session with
HAWC staff” (Asked if Q8_25 = 1).

Value:

Description:
Checked - One-on-one session with HAWC staff

1

Q8_26f

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) Web-based support program

Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) Web-based support program”
(Asked if Q8_25 = 1).

Value:

Description:
Checked - One Web-based support program

1

Q8_26g

Type: Numeric

Qcode: T26AF

ADDED 10/31/2008
Section Number: 8-Tobacco Use

Question: When you last stopped the use
of tobacco products, what did you do to
assist you with quitting? (Check all that
apply) None of the above
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Description:

Derived from response to question: “When you last stopped the
use of tobacco products, what did you do to assist you with
quitting? (Check all that apply) None of the above” (Asked if
Q8_25 = 1).

Value:

Description:
Checked - None of the above

1
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Appendix B. Distributions of the initial data set and of the five subsets

Histogram
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Figure 37: Distribution of the Initial data set
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Figure 38: Distribution of Cost for the range $0 - $600.00
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Figure 39: Distribution of Cost for the range $600.01 - $1,800.00
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Figure 40: Distribution of cost for the range $1,800.01 – 11,000.00
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Figure 41: Distribution of cost for the range $ 11,000.01 – $30,000.00
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Figure 42: Distribution of cost for the range $ 30,000.01 – $307,100.00
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Appendix C. Cook’s Distance Plots for Models 2, 3, and 4

Figure 43: Cook’s Distance Overlay Plot for Model 2

Figure 44: Cook’s Distance Overlay Plot for Model 3

Figure 45: Cook’s Distance Overlay Plot for Model 4
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